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ABSTRACT 
DESIGN OF IN VIVO ASSAYS FOR STUDY OF TRANSPORT, 
BIOCOMPATIBLITY AND TOXICITY OF NANOPARTICLES 
Kerry Jean Lee 
Old Dominion University, 2012 
Director: Dr. Xiao-Hong Nancy Xu 
This dissertation focuses on the design of new in vivo assays for study of 
transport, biocompatibility and toxicity of nanoparticles (NPs) in zebrafish 
embryos. We synthesized and purified spherical silver (Ag) NPs with diameters, 
ranging from 12 to 95 nm, that are stable (non-aggregated) in egg-water media. 
We developed new imaging approaches to characterize the sizes of single Ag 
NPs in zebrafish embryos at nanometer resolution by measuring their size-
dependent plasmonic spectra and scattering intensity using dark-field optical 
microscopy and spectroscopy (DFOMS). We used single Ag NPs because they 
exhibit the high quantum yield (QY) of Rayleigh scattering and resist 
photobleaching and blinking, allowing to be continuously monitored in vivo for any 
desired amount of time. These unique optical properties make them better than 
traditional imaging probes, such as fluorescence probes (e.g., fluorophores and 
semiconductor quantum dots), that are currently used for in vivo imaging and 
widely used in life science. With no need of fluorescence excitation, Ag NPs can 
be used to monitor transport in a living in vivo system and effectively avoids auto-
fluorescence of the living organism, allowing us to monitor it in real-time in the 
developing embryo. 
Using different properties of Ag NPs, size-dependent optical properties 
and charge-dependent surface properties, we studied transport and toxicity in 
living embryos in real-time for better understanding of biocompatibility of NPs in a 
living in vivo model system. Using Ag NPs, we continuously imaged nano-
environments of developing zebrafish embryos for hours and discovered their 
transport patterns through the chorion and into the chorion space of the different 
stages of embryos. We demonstrated that the different types of Ag NPs caused 
a wide variety of deformities and caused an increase in death, and both in a 
concentration dependent manner in living zebrafish embryos. This determined 
that zebrafish embryos are a powerful in vivo assay to use to study the transport, 
biocompatibility and toxicity of nanomaterials. 
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Nanomaterials possess unique physical and surface properties, which 
have inspired plans for a wide spectrum of applications, such as target-specific 
vehicles for in vivo sensing, diagnosis, and therapy (e.g., nanomedicine, drug 
delivery).1"5 These unique properties may also incite toxicity, damaging in vivo 
systems of interest and posing risks to human health and the environment.6 
Therefore, our primary focus was to probe the transport in real-time and 
concentration-dependent biocompatibility and toxicity of NPs in an in vivo model 
system and demonstrate the possibility of creating an in vivo assay using 
zebrafish embryos as a standard to study the biocompatibility and toxicity of 
nanomaterials. Establishing an in vivo assay enables the screening of NPs and 
determines their prospective use in a living system and the side effects caused 
by their exposure. Studying the transport and biocompatibility of NPs in real-time 
during early embryonic development will provide new information into the 
transport mechanisms and the interactions of NPs with the developing embryos. 
Different types of NPs have not yet been assessed for their biocompatibility and 
toxicity in an in vivo model system, so it is important to investigate the effects of 
their exposure. Hence, it is important to develop an in vivo assay to efficiently 
screen the biocompatibility and toxicity of NPs in real-time while investigating the 
transport mechanism. 
We used silver (Ag) NPs as our model nanomaterials to study transport 
and biocompatibility in a developing embryo model system. The reason we 
choose to use Ag NPs is because noble metal NPs possess unique optical 
properties, such as, localized-surface-plasmon resonance (LSPR), which 
dependent upon their size and shape. This allows them to be directly imaged in 
the living system without any fluorescence excitation3,7"9. Fluorescent dyes are a 
preference as probes for in vivo imaging, but these are obsolete because most 
fluorescence dyes suffer from photodecomposition and cannot be followed for a 
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long period of time during development10. Noble metal NPs, such as Ag NPs, 
have been shown to be photostable and do not demonstrate photobleaching or 
photoblinking enabling them to be used as important and powerful imaging tool11" 
15. Silver NPs are extremely bright and can be directly observed and imaged 
using dark field optical microscopy and spectroscopy (DFOMS). Unlike 
fluorescent probes and quantum dots, noble metal NPs do not suffer 
photodecomposition or photoblinking and can be used as a probe to continuously 
monitor dynamic events for an extended period of time. Moreover, the LSPR 
spectra of nanoparticles shows size dependence, thus one can use the color 
(LSPR spectra) index of these multicolor nanoparticles as a nanometer size 
index to directly measure membrane transports of nanoparticles and determine 
the size of membrane pores at the nanometer scale in real-time14, 15. Size is 
important because it influences every aspect of nanoparticle function, including 
uptake mechanisms and nanoparticle clearance. 
Zebrafish embryos were the in vivo model system of choice because they 
have characteristic beneficial features over other vertebrate model systems, such 
as the mouse, rat, and human. For example, zebrafish development is 
completed within 120 h and the stages are well documented.16"20 Additionally, 
zebrafish embryos develop outside of their mothers and are transparent, which 
makes them easy to see and observe allowing for direct observation of normal, 
dead, deformed embryos. Zebrafish also share similarities to human genes and 
diseases, and the protein sequences of drug-binding receptors in zebrafish and 
humans show a high degree of affinity.16,20 Thus, zebrafish are an important in 
vivo model system for screening drugs for use against human diseases. Lastly, 
zebrafish are ideal because they generate many embryos fast and at minimal 
cost, which is an important factor for establishing an efficient and affordable in 
vivo assay for the screening of biocompatibility of different types of NPs. 
The zebrafish as an in vivo model system has become commonplace for 
screening chemical toxicity17 and drug biocompatibility20, but it has not been used 
for the screening of biocompatibility and toxicity of NPs. Furthermore, in all 
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reported nanotoxicity studies, conventional toxicological assays were primarily 
used, which cannot characterize dose of nanoparticles in vivo and in real time. 
Typically, nanoparticles were injected into in vivo systems6,21, which is highly 
invasive. Many of these studies used unpurified nanoparticles or functionalized 
nanoparticles and did not consider effects of residual chemicals produced during 
nanoparticle synthesis persisting in nanoparticle solutions, leading to 
inconclusive results.6 
It is important to utilize this valuable in vivo model system and establish an 
assay to look at the transport, biocompatibility and toxicity of NPs. Currently, the 
biocompatibility of NPs, used as labeling agents for imaging cells and organisms, 
are not well known. The primary challenges of establishing an in vivo assay for 
screening the effects of NPs are (i) to accurately monitor the transport and the 
death, deformity and normal phenotypes produced from exposure to the NPs, (ii) 
to develop an in vivo assay that would share similarities to humans to establish 
realistic biocompatibility and toxicity goals for human treatments and (iii) to 
establish a standard in vivo assay that is efficient, easy to use, and affordable for 
screening NPs. In the following dissertation, we accomplished all of these 
objectives, achieving a major advance in the in vivo screening of NPs. 
In this dissertation, we developed new imaging and in vivo assay 
approaches to characterize the transport, biocompatibility and toxicity of different 
types of single silver (Ag) NPs, ranging from 12 to 95 nm. We imaged at 
nanometer resolution by measuring their size-dependent localized surface 
plasmon resonance (LSPR) spectra and scattering intensity in living embryos 
using dark-field optical microscopy and spectroscopy (DFOMS). These new 
approaches allowed us to characterize different types of single Ag NPs for 
simultaneous imaging of multiple single NPs in living embryos. We also were 
able to measure their sizes at nanometer resolution, with millisecond temporal 
resolution, using optical microscopy in real-time. This study offers powerful new 
tools to study multiple dynamic and molecular events of interest in vivo using 
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multiple single NP optical probes and a valuable in vivo model assay via optical 
microscopy. 
This dissertation includes seven chapters. In Chapter I, we provide a brief 
overview of the research background and significance of this dissertation 
research, and outline the contents of each chapter. 
In Chapter II, we describe the design of a standard in vivo assay that is 
efficient, easy to use, and affordable to screen the transport, biocompatibility and 
toxicity of 12 nm Ag NPs. These new approaches allowed us to create an in vivo 
assay to screen single Ag NPs for biocompatibility while simultaneously imaging 
and measuring sizes of multiple single NPs in real-time using DFOMS, as 
illustrated in Figure 1. We were able to synthesize, characterize and purify Ag 
NPs, 12 nm in size and incubated them with our living in vivo model system. We 
determined that the Ag NPs (12 nm) were stable in the egg-water media and 
were able to transport into the embryos via random diffusion causing various 
deformities in a dose-dependent manner. This study offers powerful new tools to 
study the dynamics of in vivo transport of NPs and the biocompatibility and 
toxicity of NPs, as described in Chapter lll-VI. 
In Chapter III, we utilize the Ag NP optical probes and imaging approaches 
developed in Chapter II to probe the transport kinetics of Ag NPs used in Chapter 
II in our in vivo model system at different stages of development in real-time at 
nanometer resolution, as illustrated in Figure 2. We found that NPs transport into 
the embryos in a stage-dependent manner causing stage specific related 
deformity. This experiment demonstrates that plasmonic Ag NP probes can be 
used to study the stage dependent effects during embryonic development in 
single living embryos, offering the possibility of better understanding the 
questions of development. 
In Chapter IV, we used the zebrafish embryos as our in vivo model system 
and imaging methods described in Chapter II to screen the transport, as well as 
Deformity 
Figure 1. Illustration of transport, biocompatibility and toxicity of single Ag 
NPs in zebrafish embryos as an in vivo model system via DFOMS. 
biocompatibility and toxicity of Ag NPs with different surface charges, as 
illustrated in Figure 3. Unlike other NP biocompatibility experiments, we utilized 
the purified single Ag NPs (12 nm) from Chapter II and conjugated them with 










' ̂  
V - • . 
. m S  
> 
• m 
^ • / 
* . ̂-f 
i • 









Figure 2. Illustration of probing of stage-dependent transport, 
biocompatibility and toxicity of single Ag NP probes using zebrafish 
embryos. 
Charge affects on developing zebrafish embryos in real-time. We determined 
that these Ag-peptide NPs were also stable in the egg-water media prior to 
incubation with the embryos. Interestingly, we found that our in vivo model 
system displayed charge-dependent biocompatibility and toxicity. This illustrates 
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Figure 3. Illustration of using Ag-peptide NPs as optical probes with 
varying surface charges for transport, biocompatibility and toxicity in living 
zebrafish embryos in real-time. 
the possibility of using different surface charged NPs, that are more 
biocompatible, to probe the dynamics of embryonic development. 
In Chapter V, we describe the synthesis and characterization of purified 
larger Ag NPs (42.3 ± 6.3 nm) that are stable in egg-water medium. We studied 
their biocompatibility and toxicity in vivo, as illustrated in Figure 4. Using imaging 
approaches described in Chapter II, we observed the effects of larger Ag NPs on 
the morphology, viability and transport of embryos at single NP and single live 
embryo resolution. We found that the larger Ag NPs were more toxic, showing 








Figure 4. Illustration of using larger sized 42 nm single NP optical probes 
for transport, biocompatibility and toxicity in living zebrafish embryos in 
real-time. 
demonstrating drastic changes in embryo morphology and an increase in the 
amount of dead embryos. This work demonstrates the possibility of using 
smaller Ag NPs (12 nm) as a more biocompatible embryonic probe for potential 
therapeutic drug carriers. 
In Chapter VI, we synthesized and characterized larger (95 nm) single 
molecule Ag NP optical probes, making sure that they were stable in egg-water 
media. We then used these single NP probes to map the transport and 
biocompatibility and toxicity of large NPs on single living embryos in real-time, as 
illustrated in Figure 5. We found that the larger NPs were more toxic and were 
• V \ 
60.3% Normal 10.6% D*form»d 29.1% Dead 
Figure 5. Illustration of transport of 95 nm Ag NPs in single living embryos 
and their biocompatibility and toxicity. 
The results demonstrate that size does matter when related to NPs and that 
smaller NPs are more suitable for quantitative imaging and probing of single 
living embryos for any desired period of time. This offers new possibilities for 
monitoring the dynamics of embryonic development in single living embryos in 
real-time, emphasizing the importance of the study of NP transport, 
biocompatibility and toxicity on single living embryos. 
In Chapter VII, we summarized our research findings described in the 
preceding chapters, pointed out the primary contributions of these original 
research activities, and emphasized the possible future research directions. 
10 
CHAPTER II 
REAL-TIME IMAGING OF TRANSPORT, BIOCOMPATIBILITY AND TOXICITY 
OF SINGLE 12 NM SILVER NANOPARTICLES IN EARLY DEVELOPMENT OF 
ZEBRAFISH EMBRYOS 
INTRODUCTION 
We select an effective in vivo model system (zebrafish embryos) and one 
type of model nanomaterial (12 nm Ag nanoparticles) and focus on probing the 
transport mechanism and dose-dependent biocompatibility of the nanomaterials 
in vivo, targeting the initial entry step of nanomaterials into embryos. The aim is 
to demonstrate the Ag NPs potential applications and address its potential 
adverse effects. Real-time study of transport and biocompatibility of single 
nanoparticles in early development of embryos will provide new insights into 
molecular transport mechanism and structure of developing embryos at 
nanometer (nm) spatial resolution in vivo. As well as, assess the biocompatibility 
of single nanoparticle probes in vivo. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Ag NPs 
We synthesized spherical Ag NPs with average diameter of (11.6 ± 3.5) 
nm by reducing AgCI04 with reducing agents (sodium citrate and sodium 
borohydride) using well-tuned synthesis conditions as described in Methods. We 
then carefully washed nanoparticles to remove trace chemicals from their 
synthesis using centrifugation, generating highly purified nanoparticles. We 
characterized the stability, size and optical properties of these purified Ag 
nanoparticles incubated in egg-water (1.2 mM NaCI) for 120 h using UV-vis 
absorption spectroscopy, DFOMS, dynamic light scattering (DLS), and high-
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Figure 6. Characterization of optical properties and stability of Ag 
nanoparticles. 
(A) Representative UV-vis absorption spectra of 0.71 nM Ag NPs for (i) 0 and (ii) 
120 hours (B) Representative HR-TEM images Ag NPs. Scale bar = 5 nm. (C) 
Representative dark-field optical image of single Ag NPs shows the majority are 
blue. (D) Representative LSPR spectra of single Ag NPs exhibit peak 
wavelength at 452, 531, and 601 nm, respectively. (E) Histogram of size and 
color distribution of nNPs to be 11.6 ± 3,5 nm, with 74% of 5-15 nm (blue), 23% 
of 16-30 nm (green), and 1% of 31-46 nm (red) Ag nanoparticles. (F) 
Representative plots of scattering intensity of single NPs (i) and background (ii). 
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The absorption spectra of freshly prepared and washed nanoparticles 
before and after incubating with egg-water for 120 h (Figs. 6A: a & b) show an 
absorbance of 0.736 at a peak wavelength of 396-400 nm, indicating that Ag 
nanoparticles are very stable (not aggregated) in egg-water (1.2 mM NaCI). We 
determined the effect of salt concentration (the positive control experiment) by 
increasing NaCI concentration and found that nanoparticles are stable in the 
presence of NaCI up to 10 mM, but begin to aggregate in 100 mM NaCI, showing 
a red shift of peak absorbance wavelength (~2-3 nm) and a decrease in 
absorbance. The size of nanoparticles measured by DLS increased from (10.1 ± 
2.0) nm to (24.4 ± 2.7) nm in the presence of 100 mM NaCI. The presence of 
sufficiently high concentration of NaCI (100 mM) appears to reduce the thickness 
of electric double-layer on the surface of nanoparticles and decrease the zeta 
potential below its critical point, leading to aggregation of nanoparticles. 
We characterized the size of Ag NPs using HR-TEM and DLS before and 
after incubating with egg-water for 120 h, showing that the size of nanoparticles 
remained unchanged with an average diameter of 11.6 ± 3.5 nm. Furthermore, 
we characterized the optical properties of individual nanoparticles using DFOMS 
(Fig. 6: C-F). A representative optical image of single nanoparticles in Fig. 5C 
illustrates that the majority of nanoparticles are blue with some being green and 
few are red. The representative LSPR spectra of single blue, green and red 
nanoparticles show peak wavelengths of 488, 532 and 607 nm (Fig. 6D), 
respectively. The correlation of the color distribution of individual nanoparticles 
with their size measured by HR-TEM, shows the majority (74%) of single 
nanoparticles with diameters of 5-15 nm are blue, 23% of single nanoparticles 
with diameters of 16-30 nm are green, and a very small fraction (1%) of 
nanoparticles (31-46 nm) are red (Fig. 6E). Thus, the color-index of single 
nanoparticles can be used as a size-index to directly distinguish and determine 
the size of nanoparticles (5-46 nm) using DFOMS, even though the size of 
nanoparticles cannot be directly measured due to the optical diffraction limit. We 
also found that the distribution of color and size of nanoparticles remained 
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unchanged as nanoparticles were incubated in egg-water for 120 hr, suggesting 
that nanoparticles are stable (not aggregated) in egg-water at single-nanoparticle 
resolution. 
To determine the photostability of Ag nanoparticles, we acquired 
sequence images of single Ag nanoparticles while these nanoparticles were 
constantly radiated under a dark-field microscope illuminator (100 W halogen) for 
12 hr. The illumination power at the sample stage (focal plane of dark field) was 
0.070 ± 0.001 Watt. Representative plots of scattering intensity of single 
nanoparticles and background (in the absence of nanoparticles) versus 
illumination time in Fig. 6F indicate that the scattering intensity of individual single 
nanoparticles remains unchanged over 12 h, showing that single Ag 
nanoparticles resist photodecomposition and blinking. Note that the small 
fluctuations of intensity of single nanoparticles (Fig. 6F: i) are similar to those 
observed from the background (Fig. 6F: ii), suggesting that the intensity 
fluctuations are attributable to the illuminator and the noise level of the CCD 
camera. 
Probing Diffusion and Transport of Single Nanoparticles in Cleavage Stage 
Embryos 
Representative developmental stages of the zebrafish embryos in 120 
hour-post-fertilization (hpf) in Fig. 7 show the cleavage stage (8-64 cell stages), 
segmentation stage, hatching stage, and pharyngula stage embryos, and a fully 
developed zebrafish in the absence of nanoparticles. At the cleavage-stage (8-
64 cell stage; 0.75-2.25 hpf) (Fig. 7A-B), embryos undergo dramatic changes 
(e.g., rapid cellular division and distinct fate establishment) to lay down the 
foundation for developing the different parts of organs and a variety of interesting 
but not yet well-understood biochemical and biophysical events (e.g., cell 
migration signaling and embryonic pattern formation) occur. This stage is crucial 
in development as the foundation and organization of the embryos are being 
assembled.22,23 Thus, it is important to understand the diffusion and transport 
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Figure 7. Optical images of the representative developmental stages of 
normally developed zebrafish in egg-water (in the absence of 
nanoparticles) and representative anatomical structures. 
(A) 1.25-1.50 hpf (8-cell stage); (B) 2-2.25 hpf (64-cell stage); (C) 24 hpf 
(segmentation stage); (D) 48 hpf (hatching stage); (E) 72 hpf (pharyngula stage); 
(F) a completely developed zebrafish at 120 hpf and (G) representative 
anatomical structures of the zebrafish: (i) finfold, (ii) tail region, (iii) yolk sac, (iv) 
heart, and (v) eye. Scale bar = 500 pm. hpf = hour post fertilization. 
mechanisms among the various parts of embryos at this particular stage. The 
cleavage stage embryos may also be most sensitive to foreign substances24, 
offering an ultrasensitive in-vivo model system to study the biocompatibility and 
subtle effects of nanoparticles on the embryonic development. 
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To study diffusion and transport of single nanoparticles into cleavage 
stage embryos, we incubated Ag nanoparticles with the embryos and directly 
observed and characterized their transport. We found that Ag nanoparticles 
(blue, green and red) transport into the chorionic space (cs) via chorion pore 
canals (CPCs) and enter into the inner mass of embryo (ime) (Fig. 8). We used 
our optical imaging system to directly measure the diameters of chorion pore 
canals, showing them to be approximately 0.5-0.7 pm in diameter with distances 
between the centers of two nearby chorion pore canals are at -1.5-2.5 pm, which 
agrees well with those reported using TEM.25 To our knowledge, this study 
demonstrates for the first time direct observation of chorionic pore canals of 
single living embryos using optical microscopy. We show that the sizes of 
chorion pore canals are much larger than the size of nanoparticles, permitting the 
passive diffusion of individual nanoparticles into the chorionic space of embryos. 
To determine the transport mechanism of Ag nanoparticles, we utilized the 
concept of 2D mean-square-displacement (MSD) and diffusion models (e.g., 
directed, simple and stationary Brownian diffusion)26, 27 to investigate each 
diffusion trajectory of single nanoparticles in egg-water, entry into embryos, and 
inside embryos. To follow the diffusion of single nanoparticles inside various 
parts of embryos in real-time, we used real-time square-displacement (RTSD) 
(diffusion distance at a given time interval), instead of average (mean) of square-
displacement over time, because the diffusion coefficient could vary as single 
nanoparticles diffuse in embryos. This approach allowed us to probe the 
diffusion of single nanoparticles and viscosity of the different parts of embryonic 
fluids (e.g., chorionic space, inner mass of embryo) in real-time. The diffusion 
coefficient (D) of single nanoparticles in simple Brownian motion is calculated by 
dividing the slope of a linear plot of real-time square-displacement versus time by 
4 (Note: RTSD = 4DAt). 
Representative diffusion trajectories of single Ag nanoparticles trapped 
inside chorion pore canals, in chorionic space and near the inner mass of 
embryo, and analysis of these diffusion trajectories using the real-time square-
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Figure 8. Real-time monitoring and characterization of transport of 
individual Ag nanoparticles in a cleavage-stage living embryo . 
(A) Optical image of a cleavage-stage embryo shows chorionic space (CS), yolk 
sac (YS), and inner mass of embryo (IME). (B) Sequence dark-field optical 
images illustrate the transport of single Ag nanoparticles, as indicated by the 
circle, from the egg-water (extra embryo) into the chorionic space via an array of 
chorion pore canals (CPCs) highlighted by a rectangle. (C) Sequence dark-field 
optical images illustrate the transport of single Ag NPs, as indicated by the circle, 
from chorionic space into inner mass of embryo. The straight and curved 
dashed-lines illustrate the interface of inner mass of embryo with chorionic 
space, and chorionic space with egg-water, respectively. The time interval of 
each sequence image in both (B) and (C) is 25 s. Scale bar = 400 pm in (A) and 
15 pm in (B-C). 
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displacement method are shown in Fig. 9. The results illustrate that single Ag 
nanoparticles inside the chorionic space (either near the chorion layers or inner 
mass of the embryo) exhibit simple Brownian diffusion (not active transport) with 
~26 times slower diffusion rate (3x10"9 cm2/s) than those in egg-water (7.7x10"® 
cm2/s), showing that single Ag nanoparticles diffuse into the chorionic space via 
passive diffusion and that the viscosity of chorionic space is about 26 times 
higher than that of egg-water. 
As nanoparticles make several attempts to enter the chorion layers and 
inner mass of the embryo, their diffusion patterns are restricted (Fig. 9B: a-i, 
steps in a-ii and a-iii), suggesting that the nanoparticles dock into the chorion 
pore canals, which halts their normal diffusion. By tracking the entry of individual 
nanoparticles into chorion pore canals, we measured the period of time that 
individual nanoparticles stay in the pores, which ranges from 0.1 to 15 s. 
We characterized the diffusion coefficient of blue, green and red 
nanoparticles in egg-water (Fig. 9B: b) to determine the possible variation of 
diffusion coefficients due to the different sizes (radii) of single nanoparticles, 
showing simple Brownian diffusion with D of 8.4 x10~8, 6.0 x10~8 and 5.5 x10"8 
cm2/s, respectively. The diffusion coefficients are inversely proportional to their 
radius, as described by the Stoke-Einstein equation, D = kT/(6rcria), showing that 
the diffusion coefficient (D) depends on the viscosity of medium (ri) and the 
radius (a) of solute (nanoparticle).28,29 The diffusion coefficients of the given 
color (radius) of nanoparticles in embryos were studied and compared with those 
in egg-water, showing that the various diffusion coefficients observed in three 
different parts of embryos (Fig. 9B: a) were indeed attributable to the viscosity 
gradient inside embryos, but not the different radii of individual nanoparticles. 
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Figure 9. Characterization of transport and diffusion of single Ag NPs in a 
cleavage (64-cell) stage living embryo. 
(A) Diffusion trajectories of single Ag nanoparticles: (i) a red nanoparticle inside 
the chorion layers, (ii) a blue nanoparticle inside chorionic space, and (iii) a green 
nanoparticle at the interface of inner mass of embryo and chorionic space. (B) 
Plots of real-time square-displacement (RTSD) as a function of time: (a) single 
nanoparticles from the diffusion trajectories shown in A (i-iii) illustrate that (i) a 
red nanoparticle in a restricted and stationary diffusion mode with a diffusion 
coefficient (D) < 1.9x10"11 cm2/s, due to entrapment inside chorion pore canals; 
(ii) a blue nanoparticle in chorionic space away from the inner mass of embryo; 
and (iii) a green nanoparticle inside chorionic space near the surface of inner 
mass of embryo, both in a simple Brownian motion with D of 3.4x10"9 cm2/s and 
2.6x1 CT9 cm2/s, respectively; (b) a representative single (i) blue, (ii) green and (iii) 
red nanoparticle in egg-water. All show simple Brownian diffusion with D of 8.4 
x10"8, 6.0 x10"8 and 5.5 x10"8 cm2/s, respectively. 
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Imaging and Characterization of Transport and Embedded Nanoparticies 
Images of single nanoparticies diffusing into the chorionic space were 
recorded using DFOMS equipped with a color camera, instead of CCD, showing 
that nanoparticies of multiple colors transport into the chorionic space (Fig. 10A). 
Note that single Ag nanoparticies exhibit colors (LSPR), which depends on its 
size, shape and surrounding environments.30"33 This feature allowed us to 
distinguish single Ag nanoparticies from any possible tissue debris or vesicle-like 
particles in embryos, which do not exhibit surface plasmon and hence appear 
white under dark-field microscope (Figs. 8 & 9). We found that the majority of 
NPs transported into the chorionic space and some of them overlapped with 
chorion pore canals (Fig. 10A: a). The representative LSPR spectra (colors) of 
individual nanoparticies inside chorionic space (Fig. 10A: b) show similar peak 
wavelengths as those observed in egg-water in Fig. 6D. The results indicate that 
the majority of nanoparticies remained non-aggregated inside embryos. 
Otherwise, we would have observed a significant red shift of LSPR spectra of 
individual nanoparticies. 
Although the majority of single nanoparticies can freely diffuse into 
embryos and remain non-aggregated, some single nanoparticies stay in chorion 
pore canals for an extended period of time. These trapped nanoparticies serve 
as nucleation sites and aggregate with incoming nanoparticies to form larger 
particles (dark-red nanoparticies) (Fig. 10B), clogging chorion pore canals and 
affecting the embryo's transport. Note that, embryos at this developmental stage 
are free of pigmentation. 
As the cleavage (8-cell) stage embryos chronically treated with lower 
concentrations of Ag nanoparticies (< 0.08 nM) completed their embryonic 
development at 120 hpf, we characterized Ag nanoparticies embedded in fully 
developed zebrafish using DFOMS and found that these Ag nanoparticies 
embedded in multiple organs (retina, brain, heart, gill arches, and tail) of normally 
developed zebrafish (Fig. 11), demonstrating that Ag nanoparticies are 
biocompatible to embryos at lower concentrations (< 0.08 nM). The LSPR 
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Figure 10. Characterization of Ag nanoparticles embedded in embryos 
using dark-field DFOMS. 
(A) Representative (a) color image and (b) LSPR spectra of single Ag 
nanoparticles embedded in chorion layers show that single Ag nanoparticles with 
multiple-colors (blue, green, red) are present inside chorion layers, and some 
nanoparticles are overlapped with the chorion pore canals (note that an array of 
chorion pore canals are highlighted by a triangle). Scale bar = 1 nm. (B) 
Representative images of individual Ag nanoparticles embedded in the chorion 
layers illustrate those Ag nanoparticles (as indicated by a circle) trapped in the 
chorion pore canals outlined by ellipses. The CCD image in (a) is enlarged and 
shown in (b). The zoom-in color image of (b) is shown in (c), indicating that the 
dark-red nanoparticles clog the chorion pore canals. Scale bar = 10 ^im in (a); 2 
jim in (b). OC = outside chorion 
21 
Figure 11. Characterization of individual Ag nanoparticles embedded 
inside a fully developed (120 hpf) zebrafish using DFOMS: 
(A) Optical image of a fixed normally developed zebrafish. The rectangles (i-v) 
highlight representative areas: (i) retina, (ii) brain (mesencephalon cavity), (iii) 
heart, (iv) gill arches, and (v) tail. (B) Zoom-in optical images of single Ag 
nanoparticles embedded in those tissue sections outlined in (A). Dashed circles 
outline the representative embedded individual Ag nanoparticles. Scale bar = 
400 pm in (a); 4 pm in (b). 
9A:b. We also performed blank control experiments by imaging 120-hpf 
zebrafish that developed in the absence of nanoparticles and did not observe the 
signature LSPR spectra (color) of Ag nanoparticles in these fully developed 
zebrafish. 
Dose-dependent biocompatibility and toxicity 
To determine the effect of dose of Ag nanoparticles on embryonic 
development, we treated the cleavage stage (8-cell stage) embryos chronically 
with various concentrations of Ag nanoparticles (0 - 0.71 nM) and carefully 
monitored and characterized their vital developmental stages (24, 48, 72, 96, and 
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120 hpf). The results in Fig. 12 A & B show that biocompatibility of Ag 
nanoparticles and the types of abnormalities in treated zebrafish are highly 
dependent on the dose of Ag NPs. In the presence of lower concentrations (< 
0.08 nM) of nanoparticles, a higher percentage of normally developed zebrafish 
is observed than that of dead and deformed zebrafish. Note that both normal 
and deformed zebrafish developed from the cleavage (8-cell) stage embryos that 
had been simultaneously incubated with the same nanoparticle solution. Thus, 
the results suggest that some embryos might be more tolerant to the 
nanoparticles than others. The results also suggest that Ag nanoparticles might 
affect the development of embryos stochastically due to the random diffusion of 
nanoparticles. 
As nanoparticle concentration increases, the number of normally 
developed zebrafish decreases, while the number of dead or deformed zebrafish 
increases (Fig. 12: a). As nanoparticle concentration increases beyond 0.19 nM, 
only dead and deformed zebrafish are observed, showing a critical concentration 
of Ag nanoparticles on the development of zebrafish embryos (Fig. 12). The 
blank (negative) control experiments, conducted by replacing nanoparticles with 
the supernatant resulting from washing Ag nanoparticles, show that the survival 
rate of zebrafish is independent of the dose of supernatant (Fig. 12: b), 
demonstrating that residual chemicals from nanoparticle synthesis are not 
responsible for the deformation and death of zebrafish, but rather the 
nanoparticles that were used to treat the zebrafish embryos (Fig. 12: a). 
The number of deformed zebrafish increased to its maximum as 
nanoparticle concentration increased to 0.19 nM, and then decreased as 
nanoparticle concentration increased from 0.19 to 0.71 nM (Fig. 12: c) because 
the number of dead zebrafish increased. Interestingly, the types of viable 
deformities exhibit high dependence on the nanoparticle concentration (Fig. 12: 
d). For example, the finfold abnormality and tail/spinal cord flexure and 
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Figure 12. Biocompatibility and toxicity of nanoparticles show high 
dependence on nanoparticle concentration. 
Histogram of distribution of normally developed (•) and dead (•) zebrafish, (a) 
versus concentration of Ag nanoparticles; (b) versus concentration of 
supernatants resulting from washing Ag nanoparticles (negative control); (c) 
histogram of distribution of deformed zebrafish (120 hpf) (•) versus concentration 
of Ag nanoparticles; (d) histogram of distribution of five representative types of 
deformities of the zebrafish versus concentration of Ag nanoparticles: finfold 
abnormality (•), tail and spinal cord flexure and truncation (•), cardiac 
malformation (•), yolk sac edema (•), head edema (•), and eye abnormality (•). 
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concentrations (0.04-0.71 nM) with the highest occurrences at 0.19 and 0.38 nM, 
respectively. Cardiac malformation and yolk sac edema were observed in 
zebrafish treated with the slightly higher nanoparticle concentrations (0.07-0.71 
nM) with the highest occurrences at 0.66 nM. In contrast, head edema and eye 
deformity were only observed in the higher concentrations of nanoparticles, 0.44-
0.71 and 0.66-0.71 nM, respectively. Among all types of observed deformities, 
finfold abnormality occurred at the highest rate, followed by tail and spinal cord 
flexure and truncation, then cardiac malformation and yolk sac edema, and finally 
head edema and eye abnormality, which were rarely observed deformations of 
zebrafish and quickly led to zebrafish death. 
Representative deformed zebrafish induced by nanoparticles are 
illustrated in Fig. 13:b-g. In comparison with the normally developed zebrafish in 
Fig. 13-a, we found characteristics of finfold abnormality (Fig. 13-b), tail and 
spinal cord flexure and truncation (Fig. 13-c), cardiac malformation (Fig. 13-d), 
yolk sac edema (Fig. 13-e), head edema (Fig. 13-f), and eye abnormality (Fig. 
13-g) of zebrafish that developed from the 8-cell embryos treated chronically by 
Ag nanoparticles. Interestingly, multiple deformities occurred in one zebrafish at 
the higher nanoparticle concentrations (> 0.38 nM). For example, in yolk sac 
edema zebrafish, we also observed tail/spinal cord flexure, finfold abnormality, 
and cardiac malformation (Fig. 13: c-iv & e-ii), head edema (Fig 13: e-ii, e-iv and 
f-ii), and eye abnormality (Fig 13: g-i). These findings suggest that specific 
embryonic developmental pathways might be co-regulated, and that some 
deformities (e.g., finfold, tail, spinal cord) are much more sensitive to the 
nanoparticles than others (e.g., head edema, eye abnormality). 
To determine the possible targets for further genomic and proteomic 
studies and evaluate the toxicity of Ag nanoparticles against well-studied toxic 
chemicals, such as cadmium, dichloroacetic acid (DCA), 2,3,7,8-
tetrachlorodibenzo-p-dioxin (TCDD), and ethanol, we compare the characteristics 
of deformation of zebrafish induced by Ag nanoparticles with those generated by 
well-known toxic chemicals. We found that the observed finfold abnormality and 
tail/spinal cord flexure and truncation induced by Ag nanoparticles (Fig. 13: b & c) 
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Figure 13. Biocompatibility and toxicity of nanoparticles show high 
dependence on nanoparticle concentration. 
Representative optical images of (a) normally developed and (b-g) deformed 
zebrafish: (a) the normal development of (i) finfold, (ii) tail/spinal cord, (iii) 
cardiac, (iii-iv) yolk sac, cardiac, head and eye; and (b-g) deformed zebrafish: (b) 
finfold abnormality; (c) tail and spinal cord flexure and truncation; (d) cardiac 
malformation; (e) yolk sac edema; (f) head edema: (i) head edema; (ii) head 
edema and eye abnormality; (g) eye abnormality: (i) eye abnormality; (ii) eyeless. 
Scale bar = 500 (jm. 
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are similar to those treated by DCA and cadmium34, 35, indicating possible 
common targets of malformation during development. The observed cardiac 
malformation and yolk sac edema in this study (Fig. 13: d & e) are also similar to 
those treated with DCA and cadmium.34,35 The shrunken ventricular myocardium 
observed in cardiac malformed zebrafish induced by nanoparticles (Fig. 13: d) is 
similar to those treated with TCDD.36 Head edema and eye abnormality in Fig. 
13B: f & g-i have also been found in treatment of zebrafish with cadmium.34 
Although the eye malformation (a cycloptic eye development) had been 
observed in zebrafish treated by ethanol,37 the deformation is unlike what we 
have observed (eyeless, no formation of retina or lens) in Fig. 13B: g-ii. Thus, 
the eyeless deformation (Fig. 13B: g-ii), an undeveloped set of optic cups with no 
retina or eye lens, to our knowledge, is a new occurrence of malformation that 
has not been reported previously. This abnormality may be related to the 
nanoparticles disrupting the regulators or signaling cascades involved with the 
normal development of the neural retinal layers and the lens of the zebrafish's 
eye. Pax-6, a transcription factor, has been studied and shown to affect the 
development of the eye retinal layers. In Pax-6 mutants, the lens fails to 
develop.37, 38 However, another transcription factor, Six-6, regulating neural 
retinal development in zebrafish has not been studied in detail and it may also 
play the role in eye deformation as well.38 Further studies are needed to 
determine whether Ag nanoparticles inhibit or regulate the expression of 
transcription factors (e.g., Pax-6 and Six-6), leading to the eyeless deformation. 
Plausible explanations for the high dependence of embryonic 
abnormalities on the dose of nanoparticles include the following: (i) The rate of 
passive diffusion (permeability) and accumulation of nanoparticles in chorion 
pore canals and embryos highly depends on the concentration gradient of 
nanoparticles. Thus, the dose of nanoparticles plays a vital role in determining 
the rate and amount of nanoparticles that can penetrate into particular 
compartments of embryos, and the rate and number of chorion pore canals 
blocked by the aggregation of nanoparticles (Figs. 9-11). (ii) The accumulated 
nanoparticles inside embryos can also alter the charge, diffusion, and 
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interactions of biomolecules (e.g., nucleic acids, proteins such as transcription 
factors, signaling molecules) in a dose-dependent manner, leading to 
interference or malfunctioning of signaling cascades. 
Taken together, these results suggest that specific pathways of embryonic 
development respond to Ag nanoparticles in a dose dependent manner, and 
demonstrate that the nanoparticles may elicit unique response from embryonic 
neural development pathways. The study demonstrates the possibility of fine-
tuning the dose of nanoparticles to (i) selectively target specific pathways to 
create particular phenotypes, (ii) selectively generate specific mutations in 
zebrafish, and (iii) serve as potential therapeutic agents to treat specific disorders 
in embryonic development. Unlike other chemicals, single nanoparticles can be 
traced and imaged inside developing embryos and developed zebrafish with 
nanometer spatial resolution in real-time, offering new opportunities to unravel 
the related pathways that lead to the abnormalities. Work is in progress to 
identify the related specific pathways and signaling cascades at the genomic and 
proteomic levels and to further explore potential therapeutic effects of 
nanoparticles. 
SUMMARY 
In summary, we have designed, synthesized and characterized single 
nanoparticle optical probes (individual Ag nanoparticles) for probing their 
transport, biocompatibility and toxicity in early development of zebrafish embryos 
in real-time. We have shown that single Ag nanoparticles resist 
photodecomposition and blinking and can be directly monitored in embryos for an 
extended period of time. Furthermore, individual Ag nanoparticles exhibit size-
dependent LSPR spectrum (color), which permits us (i) to distinguish them from 
tissue debris and vesicles in embryos, (ii) to directly image and characterize the 
sizes of individual nanoparticles in solution and in living embryos in real time, (iii) 
to probe their diffusion, transport mechanism and biocompatibility in living 
embryos in real time, and (iv) to investigate the embryonic fluids (e.g., viscosity) 
at nm spatial resolution in real time. We found that individual Ag nanoparticles 
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can passively diffuse into developing embryos via chorion pore canals, create 
specific effects on embryonic development and selectively generate particular 
phenotypes in a dose-dependent manner. The early embryos are highly 
sensitive to the nanoparticles, showing the possibility of using zebrafish embryos 
as an in vivo assay to screen the biocompatibility and toxicity of nanomaterials. 
This study represents the first direct observation of passive diffusion of 
nanoparticles into an in vivo system (an important aquatic species), suggesting 
that the release of large amounts of Ag nanoparticles into aquatic ecosystems 
(e.g., rivers) may have drastic environmental consequences, should the sizes of 
nanomaterials remain unchanged during environmental transport. This study 
also represents the first most rigorous study and characterization of nano-toxicity 
and nano-biocompatibility ever performed by investigating the effect of highly 
purified nanoparticles in vivo in real time and considering the effect of possible 
trace chemicals from nanoparticle synthesis. 
METHODS 
Reagents and Supplies 
Sodium citrate (99%), AgCI04 (99%), NaBH4 (98%), and NaCI were 
purchased from Sigma-aldrich. All reagents were used as received. The 
nanopure water (18 MQ water, Barnstead) was used to prepare all solutions and 
rinse glassware. 
Synthesis and Characterization of Ag NPs 
Silver nanoparticles were synthesized by reducing a 0.1 mM silver 
perchlorate solution with a freshly prepared ice-cold solution of 3 mM sodium 
citrate and 10 mM sodium borohydride under stirring overnight, and filtered 
through a 0.22 pm filter.39, 40 The nanoparticles were washed twice with 
nanopure water using centrifugation to remove the chemicals involved in 
nanoparticle synthesis, and the nanoparticle pellets were resuspended in 
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nanopure water before incubating with embryos. The washed Ag nanoparticles 
are very stable (non-aggregated) in nanopure water for months and remain 
stable in egg-water throughout the entire experiments (120 hpf). The 
supernatants of nanoparticle solutions after the second washing were collected 
for control experiments to study the effect of trace chemicals involved in 
nanoparticle synthesis on the development of embryos. The concentration, 
optical properties, and size of nanoparticles were characterized using UV-vis 
spectroscopy, dark-field optical microscopy and spectroscopy (DFOMS)40"42, 
high-resolution transmission electron microscopy (HR-TEM) (FEI Tecnai G2 F30 
FEG), and dynamic light scattering (DLS) (Nicomp 380ZLS particle sizing 
system), respectively. Our DFOMS has been well described previously for real­
time imaging and spectroscopic characterization of single nanoparticles in single 
living cells and for single molecule detection.29,4CM4 The detector, EMCCD or LN 
back-illuminated CCD camera coupled with a Spectra Pro-150 (Roper Scientific), 
was used in this study. All chemicals were purchased from Sigma and used 
without further purification or treatment. 
To determine the photostability of single Ag nanoparticles, we acquired 
sequence images of single Ag nanoparticles using EMCCD camera with 
exposure time at 100 ms and readout time of 40.6 ms while these nanoparticles 
were constantly radiated under dark-field microscope illuminator (100 W halogen) 
for 12 hr. The illumination power at the sample stage (focal plane of dark field) is 
0.070 ± 0.001 Watt. The integrated scattering intensity of single nanoparticles 
and background (in the absence of nanoparticles) within a 20x20 CCD pixel area 
was measured. The integrated scattering intensity of background is subtracted 
from that of same size of detection area in the presence of individual 
nanoparticles to calculate the scattering intensity of single nanoparticles. The 
experiments were repeated at least three times. The average subtracted 
integrated intensity of the single nanoparticles and background was plotted as a 
function of time. The fluctuations of intensity of single nanoparticles were used to 
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compare with those of background to determine the photostability 
(photodecomposition and blinking) of single nanoparticles. 
Breeding and Monitoring of Zebrafish Embryos 
Wildtype adult zebrafish (Aquatic Ecosystems) were maintained, bred, and 
collected, as described previously.45 Embryos were collected and transferred 
into a petri dish containing egg-water (1.2 mM stock salts in Dl water), washed 
twice with egg-water to remove the surrounding debris, and placed into 24-well 
plates with each well containing two embryos in egg-water. Each developmental 
stage of embryos in the wells was directly imaged by bright-field optical 
microscopy using an inverted microscope equipped with a 4x objective and a 
digital camera. 
In vivo Characterization and Analysis of Transport and Dose-dependent 
Biocompatibility and Toxicity of Nanoparticles 
Cleavage-stage living embryos (8-64 cell stage; 0.75-2.25 hpf) that had 
been incubated with 0.19 nM nanoparticles for a given time (0-2 hours) were 
either immediately imaged to investigate the transport of nanoparticles into 
embryos or carefully rinsed with Dl water to remove external nanoparticles, and 
placed in a self-made microwell containing Dl water to image the diffusion and 
transport of nanoparticles inside the embryos in real-time using our DFOMS. 
To study the dose-dependent effects of nanoparticles on embryonic 
development, a dilution series of washed Ag nanoparticle solutions (0, 0.04, 0.06, 
0.07, 0.08, 0.19, 0.38, 0.57, 0.66, and 0.71 nM) were incubated chronically with 
cleavage (8-celi) stage embryos in egg-water for 120 hpf. Each experiment was 
carried out at least three times and total number of embryos at 35-40 was studied 
for each individual concentration to gain representative statistics. Nanoparticle 
concentrations were calculated as described previously.46 Embryos in egg-water 
in the absence of nanoparticles and in the presence of supernatant were placed 
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in two rows of the 24-well plates as control experiments of untreated embryos 
and probing the effect of possible trace chemicals from nanoparticle synthesis, 
respectively. The embryos in the 24-well plates were incubated at 28.5°C, and 
directly observed at room temperature using an inverted microscope equipped 
with a digital camera at 24, 48, 72, 96, and 120 hpf. 
Characterization of Nanoparticles Embedded Inside Embryos and Fully 
Developed Zebrafish 
To characterize the embedded nanoparticles in the tissues of treated 
zebrafish, we selected living developed zebrafish that had been chronically 
incubated with a given concentration (0.04 nM) of nanoparticles for 120 hpf since 
their cleavage (8-cell) stage, and carefully rinsed the zebrafish with Dl water to 
remove external nanoparticles. The fixed zebrafish were prepared using 10% 
buffered formalin via a standard histology protocol of tissue sample preparation.47 
The thin-layer microsections (~5 pm thickness) were prepared by carefully 
dissecting tissues of interest (e.g., eye retina, brain, heart, gill arch, tail and 
spinal cord) under microscopy using microtome. The embedded nanoparticles in 
the tissues were directly characterized using DFOMS (Fig. 11). 
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CHAPTER III 
STUDY OF STAGE DEPENDENT TRANSPORT, BIOCOMPATIBILITY AND 
TOXICITY OF SINGLE 12 NM SILVER NANOPARTICLES USING EARLY 
DEVELOPMENT OF ZEBRAFISH EMBRYOS 
INTRODUCTION 
Nanoparticles (NPs), with their small size and unique physical properties, 
are ideal for use in probing the nano-environments of living organisms enabling 
the study of the changing environment of a developing living organism at specific 
developmental stages of embryonic development.3,9i 48"50 NP probes can be 
used in a variety of applications for new insight into developmental processes, 
such as development screening tools in developmental biology to investigate the 
embryonic internal environment, to potentially control and regulate certain 
processes in development, and to target specific system regulators for 
biomedical biological uses. Nanomaterials could possibly demonstrate 
developmental stage dependent regulation of deformity type induced, suggesting 
that the nanomaterials, at higher concentration, may interact with target 
developmental pathways of interest. In this study, we used our previously 
described nanomaterials,11 Ag NPs, and an effective embryo developmental 
model system, zebrafish embryos, and focused on acute developmental stage-
dependent diffusion and biocompatibility targeting important developmental 
stages for analysis and independent NP entry into each embryonic stage, hoping 
to identify possible developmental stage applications and the ability for NPs to 
enter the developing embryo independent of the time of development. 
The zebrafish has been used as a model organism for many chemical-
screening and drug studies; however the acute biocompatibility on different 
zebrafish developmental stages is limited.51,52 The acute biocompatibility of Ag 
NPs on specific sensitive stages of embryonic development has, to our 
knowledge, never been attempted. It is important to explore the transport and 
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biocompatibility of Ag NPs acutely at specific stages of embryonic development 
to access the ability of Ag NPs to be used for in vivo imaging at any embryonic 
stage of development as well as probes in real-time to explore the changing 
embryonic environment during development. 
The main challenges of using NP probes for specific developmental 
stages for in vivo imaging and probing the environmental changes of the 
developing embryo are (i) to ensure that the NPs transport into the embryo 
environment regardless of the stage of development into the physiological 
medium without any aid, such as microinjection (ii) to be able to track the 
transport, diffusion and characterization of individual NPs in vivo at different 
embryonic stages of development to study the differences in the embryonic fluid 
environment, and (iii) to be able to study the biocompatibility of the NPs at 
specific stages of embryonic development to assist in determining the NP 
interactions. In this study, we have accomplished all of these objectives, 
achieving a major advance in the study of single NPs in vivo. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Ag nanoparticles (NPs) 
We used our previously developed sphere-shaped silver-based 
nanoparticles that were washed to remove any chemicals that remained from the 
synthesis to study their interactions and biocompatibility with key stages in 
developmental biology to determine Ag NPs role in developmental processes, 
including stage dependent morphological responses and concentration 
dependent morphological responses, for the potential of use as developmental 
intermediates for biomedical applications.11 We characterized the stability, size 
and optical properties of the purified Ag NPs in egg-water embryo media (1.2 mM 
NaCI) for 120 hrs using UV-vis absorption spectroscopy, dark field optical 
microscopy and spectroscopy (DFOMS) and high resolution transmission 
electron microscopy (HRTEM). 
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We characterized the size of the Ag NPs using HRTEM and the size was with an 
average diameter of 13.1 ± 2.5 nm (Fig. 14A and B). A representative optical 
image of Ag NPs in Fig. 14C illustrates that majority of NPs appear to be blue 
with some green and a few red. These results suggest that Ag NPs are uniform 
in size and shape based on their color (LSPR). The representative LSPR 
spectra of single blue, green and red Ag NPs with peak wavelengths (Amax) at 
468 nm (blue) (FWHM = 38 nm), 554 nm (green) (FWHM = 47 nm), and 659 nm 
(red) (FWHM = 47) nm, respectively (Fig. 14D). Thus color of Ag NPs can be 
used as size index to directly distinguish and determine the size of NPs using 
DFOMS, even though size of NPs cannot be directly measured due to the optical 
diffraction limit. The number of NPs per image, using 20 images, at to, t0 +12h, to 
+24h, to +48h, to +72h, to + 96h and to +120h were determined to be 65 ± 0, 66 ± 
2, 67 ± 3, 67 ± 4, 70 ± 5, 67± 3 and 67± 4 (Fig. 14E). We found that the number 
of NPs remained relatively unchanged when incubated in egg-water for 120 hrs. 
The absorbance spectra of freshly prepared and purified Ag NPs before and after 
the incubation time with egg-water demonstrated a peak wavelength (Amax) at 392 
nm (FWHM = 64 nm) and remained unchanged for 120hrs (Fig. 14F). The 
unchanged number of NPs and stable absorbance spectra indicates that the Ag 
NPs are very stable in egg-water media and remain non-aggregated. 
Characterization of transport of nanoparticles (NPs) in different stage 
embryos 
The normal course of embryonic development in zebrafish in the absence 
of NPs for each acute treatment stage is depicted in Fig 15. Acute treatment 
occurred at five different stages of development for a 2 h incubation time with 
NPs: stage I, cleavage stage (2-4 hpf) (Fig. 15A (a)), stage II, gastrula stage (6- 8 
hpf) (Fig. 15A (b)), stage III, early segmentation stage (12 -14 hpf) (Fig. 15A (c)), 
stage IV, late segmentation stage (21- 23 hpf) (Fig. 15A (d)) and stage V, during 
the hatching period (48 - 50 hpf) (Fig. 15A (e)). The stages were determined by 
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Figure 14. Characterization of optical properties and stability of Ag NPs 
(A) Representative HRTEM image demonstrates the size and spherical shape of 
single Ag NPs. Scale bar = 10 nm. (B) Histogram of size distribution of Ag NPs 
measured by HRTEM shows the average size to be 13.1 ± 2.5 nm. (C) 
Representative dark-field optical image of single Ag NPs shows that majority of 
NPs are blue with some green and red. Scale bar = 2 pm. (D) LSPR spectra of 
single Ag NPs with multiple colors (blue, green, and red), with peak wavelengths 
(Amax) at (a) 468 nm (blue) (FWHM = 38 nm), (b) 554 nm (green) (FWHM = 47 
nm), and (c) 659 nm (red) (FWHM = 47 nm). (E) The # of NPs/ image (20 
images) at to, to +12h, to +24h, to +48h, to +72h, to + 96h and to +120h were , 65 ± 
0, 66 ± 2, 67 ± 3, 67 ± 4, 70 ± 5, 67± 3 and 67± 4. (F) Representative UV-Vis 
absorption spectra of 0.70 nM Ag NPs well-dispersed in egg-water at 28°C for (a) 
0 and (b) 120 h shows the peak absorbance at 0.491 and peak wavelength at 
392 nm (FWHM = 64 nm) and remains unchanged for 120 h. 
choosing critical events in embryonic development for study with NP transport 
and biocompatibility. During stage I, embryos undergo dramatic changes, such 
as rapid cellular division and embryonic pattern formation.22,23 During stage II, 
embryos undergo cell movements and migration and establishment of the early 
organ systems.53' 54 In stage III, embryos begin somitogenesis and notochord 
formation, which is important for proper development of the axial skeleton, the 
vertebrate spinal column, and the skeletal muscle.53,55 During stage IV, embryos 
undergo development of the circulatory system and the heart is being formed.53 
During stage V, the embryo is in the hatching stage and finishing its 
development. It is important to understand the diffusion and transport 
mechanisms among the various embryonic stages to investigate the differences 
in the embryonic environment and determine which developmental process may 
be most sensitive to the NPs. 
Embryos at each stage were observed throughout development after acute 
treatment with NPs. Stage I - IV embryos were observed after acute treatment at 
24 hours post fertilization (hpf) (Fig. 15B (a)), 48 hpf, (Fig. 15B (b)), 72 hpf, (Fig 
15B (c)), 96 hpf, (Fig. 15B (d)), and 120 hpf, (Fig. 15B (e)). Stage V embryos 
were observed after acute treatment at 72 hpf through 120 hpf, (Fig. 15B (c-e)). 
Probing transport and diffusion of single Ag NPs in different stage 
embryos 
To study the transport and diffusion of single Ag NPs into different stage 
embryos, we incubated 0.2 nM Ag NPs at the specific embryonic developmental 
stages as demonstrated in Figure 16 A-E and directly observed and 
characterized their transport at important areas of transport into the embryo 
through the chorion layers (CL) (Fig. 16A-E (a)) into the chorionic space (CS) 
(Fig. 16A-D (b)) via the chorion pores and into the inner mass of the embryo 
(IME) (Fig. 16A-D (c)). We were not able to characterize transport of the Ag NPs 
in the CS and IME of stage V due to the movement of the zebrafish larvae. We 
used our state of the art optical imaging system to directly measure the transport 
r 
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Figure 15. Normally developed zebrafish at stages I - V at the time of acute 
treatment and observations after acute treatment. 
(A) Representative optical images of normally developed zebrafish at the time of 
acute treatment for stage I - V, (a) 2 hpf (cleavage stage); (b) 6 hpf (early 
gastrula stage); (c) 12 hpf (early segmentation stage); (d) 21 hpf (late 
segmentation stage) and (e) 48 hpf (hatching stage). (B) Representative optical 
images of normally developed zebrafish observations after acute treatment for 
stages I - IV, (a) 24 hpf (late segmentation stage); (b) 48 hpf (hatching stage); (c) 
72 hpf (pharyngula stage); (d) 96 hpf larvae and (e) 120 hpf fully developed 







Figure 16. Characterization of Ag NPs in zebrafish embryos using DFOMS. 
Representative optical images of (A) stage I (cleavage stage) embryo, (B) stage 
II (early gastrula stage) embryo, (C) stage III (early segmentation stage) embryo, 
(D) stage IV (late segmentation stage) embryo, and (E) stage V (hatching stage) 
larvae. Areas where single Ag NPs were characterized, in the (a) extra-surface 
of the chorion layers (CL); (b) in the chorion space (CS) and (c) in the inner mass 
of the embryo (IME), as indicated by the squares. Note that only (a) was 
characterized in stage V due to the movement of the zebrafish larvae at this 
stage. Scale bar = 500 pm. (F) Representative LSPR spectra of single Ag NPs 
observed in the CL showing multiple colors (blue, green, and red) are present, 
with peak wavelengths (Amax) at 490 nm (blue) (FWHM = 33 nm), 560 nm (green) 
(FWHM = 34 nm), and 610 nm (red) (FWHM = 40 nm). 
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of Ag NPs at each different stage of embryonic development and determined that 
NPs entered the chorion at each stage regardless of the stage of development. 
Single Ag NPs found in the embryonic chorion to be characterized were brought 
into focus and the LSPR spectra were determined after suitable background 
subtraction. Spectra of control embryos were measured in an identical manner 
to ensure that the optical property of the embryonic tissue doesn't overlap with 
that of the Ag NPs. A representative result of LSPR spectra is shown in Figure 
16F. 
We employed the concept of 2D mean-square-displacement (MSD) and 
diffusion models (e.g., directed, simple and stationary Brownian diffusion)26,27 to 
investigate the diffusion trajectory of single NPs in each embryonic stage of 
development following the entry into embryos and inside embryos. To follow the 
diffusion of single NPs inside different stage embryos in real-time, we used real­
time square-displacement (RTSD) (diffusion distance at a given time interval), 
instead of average (mean) of square-displacement over time, because the 
diffusion coefficient could vary as single NPs diffuse in embryos. Doing this 
allowed the probing of diffusion of single NPs and viscosity of different areas of 
the embryonic fluid environment, such as the chorionic space or the inner mass 
of the embryo in each different stage embryo in real-time. The diffusion 
coefficient (D) of single NPs in simple Brownian motion is calculated by dividing 
the slope of a linear plot of real-time square-displacement versus time by 4 
(Note: RTSD = 4DAt). 
Representative optical images and diffusion trajectories of single Ag NPs 
trapped inside the pores of the chorion layers (CL) at the interface with egg-water 
and analysis of these diffusion trajectories using the real-time square-
displacement method for each developmental stage are shown in Figure 17. The 
results illustrate that as single Ag NPs make several attempts to enter the CL, 
their trajectory and diffusion patterns are constrained (Fig. 17, A-E, (a-c)), 
suggesting that the NPs dock into the chorion pores, which halts their normal 
trajectory and diffusion patterns. The representative D values of the green Ag 
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Figure 17. Characterization of transport and diffusion trajectories of single 
Ag NPs in acute treatment stages I - V at the chorion layers (CL). 
Representative (a) optical images of the interface of the chorion with egg-water, 
where single green Ag NPs (dashed circles) from outside chorion (OC) through 
the pores (outlined in (C) by the dashed square) of the CL, represented by the 
dashed lines, were monitored for the (b) diffusion trajectory and (c) real-time 
square displacement (RTSD) as a function of time for stages I - V. (A) Stage I 
exhibits constrained motion with D = 2.65 x 10"10± 2.43 x 10"10cm2 s"1. Scale bar 
= 10 pm (a) and 400 nm (b). (B) Stage II shows constrained motion with D = 
2.26 x 10"10 ± 2.08 x 1O~10cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). (C) 
Stage III illustrates constrained motion with D = 7.54 x 10"1°± 9.77 x 10~10cm2 s~1. 
Scale bar = 10 pm (a) and 800 nm (b). (D) Stage IV displays constrained motion 
D = 8.12 x 10"10 ± 0.12 x 10~10 cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). 
(E) Stage V demonstrates constrained motion with D = 6.04 x 10"10 ± 8.02 x 10" 
10cm2 s"1. Scale bar = 10 pm (a) and 200 nm (b). 
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NPs for stages I through V were (2.65 ± 2.43) x 10"10, (2.26 ± 2.08) x 10"10, (7.54 
± 9.77) x 10"10. (8.12 ± 0.12) x 10 *10, and (6.04 ± 8.02) x 10~10 cm2 s'\ 
respectively. The data for stages I through V all showed similar findings and this 
was in accordance with our previous recorded diffusion data.11 We were able to 
track the entry of individual nanoparticles into the chorion of each developmental 
stage. 
Once the Ag NPs are inside the chorionic space (in-between the CL or 
inner mass of the embryo (IME)) we characterized the D values of the NPs (Fig. 
18) to determine the possible variation of D values due to the different viscosities 
of the embryonic environment during that time of development. The D values are 
inversely proportional to their radius, as described by the Stoke-Einstein 
equation, D = kT/(6nr|a), showing that the D depends on the viscosity of 
environment (ti) and the radius (a) of solute (NP).28,29 In our previous studies, 
the diffusion coefficients of the given color (radius) of NPs in embryos were 
studied and compared with those in egg-water, showing that the various diffusion 
coefficients observed in three different parts of embryos were due to the viscosity 
of embryonic environment. Simple diffusion (not active transport) with slower 
diffusion rates than those in egg-water, demonstrate that single Ag NPs diffuse 
into the chorionic space via passive diffusion and that the viscosity of the 
chorionic space is higher than that of egg-water.11,13 
There was a difference in the characterized trajectories and D values 
dependent on the stage of development in the chorionic space (Fig. 18, A-D, (a-
c)). Stage I through IV, characterization of single NPs in the chorion space, all 
displayed simple Brownian diffusion with representative D values of green NPs of 
(3.35 ± 1.15) x 10"9, (7.29 ± 5.36) x 10"10, (3.31 ± 2.05) x 10'10 and (9.82 ± 3.96) x 
10"10cm2 s"\ respectively. Stage I D values were higher than the D values of 
stage II through IV suggesting that the environmental viscosity in stages I is 
lower. This is consistent with literature in that during this period of development 
(stage I) gene expression has been found to be lower as compared to stages II -
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Figure 18. Characterization of transport and diffusion trajectories of single 
Ag NPs in the chorion space (CS) in acute treatment stages I - V. 
Representative (a) optical images of the CS, where single green Ag NPs (dashed 
circles) in-between the CL and the inner mass of the embryo (IME), represented 
by the dashed lines were monitored for the (b) diffusion trajectory and (c) real­
time square displacement (RTSD) as a function of time for stages I - V. (A) 
Stage I exhibits simple Brownian motion with D = 3.35 x 10"9± 1.15 x 10"9cm2 s"1. 
Scale bar = 10 pm (a) and 1 pm (b). (B) Stage II shows simple Brownian motion 
with D = 7.29 x 10"10 ± 5.36 x 10"10cm2 s"1. Scale bar = 10 pm (a) and 1 pm (b). 
(C) Stage III illustrates simple Brownian motion with D = 3.31 x 10"10± 2.05 x 10" 
10cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). (D) Stage IV displays simple 
Brownian motion with D = 9.82 x 10"10 ± 3.96 x 10"10cm2 s~1. Scale bar = 10 pm 
(a) and 1 pm (b). 
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IV.56 The lower expression of genes at this time would indicate that there are 
fewer proteins being translated at this time and the biomolecule content in the 
chorion space would be less resulting in a less viscous environment, which is 
consistent with a higher diffusing rate observed in stage I. In stages II and IV the 
diffusion appears restricted and the D values are lower suggesting that the 
viscosities of the chorion space of the embryonic environment are more 
concentrated during these stages of development. The increased viscosity 
correlates with these periods of development because during stage II many 
genes are starting to be expressed and in stage III and IV many more genes are 
being expressed during the segmentation period to aid in the development of the 
organ systems and require many signaling pathways and biomolecules to 
complete proper development.56 The trajectories in the chorionic space (Fig. 18, 
A-D, (b)) also varied with each stage demonstrating that there are different 
viscosities and fluid flow dynamics of the changing embryonic environment 
during development. We were not able to accurately characterize diffusion and 
trajectories of the NPs in the chorionic space for the stage V embryos due to the 
movement of the live embryo. 
We also characterized the diffusion coefficients of the NPs at the surface 
of the inner mass of the embryo (IME). Representative diffusion trajectories of 
single Ag NPs at the surface of the IME and analysis of these diffusion 
trajectories using the real-time square-displacement method for each 
developmental stage are shown in Figure 19, A-D (a, b).. The results illustrate 
that as single Ag NPs make several attempts to enter the embryonic mass their 
diffusion patterns are confined (Fig. 19, A-D (c)), suggesting that the NPs come 
in contact with the developing embryonic mass, which arrests their normal 
diffusion. The representative D values of green NPs for stages I through IV were 
(3.07 ± 0.22) x 10"10, (9.73 ± 7.19) x 10'10, (9.91 ± 8.35) x 10'10and (6.79 ± 3.27) x 
10"10 cm2 s"1, respectively. Again, we were not able to accurately characterize 
diffusion and trajectories of the NPs in the inner embryonic mass for the stage V 
embryos due to the movement of the live embryo. 
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Figure 19. Characterization of transport and diffusion trajectories of single 
Ag NPs in the inner mass of the embryo (IME) in acute stages I - V. 
Representative (a) optical images of the IME, represented by the dashed lines 
where single green Ag NPs (dashed circles), were monitored for the (b) diffusion 
trajectory and (c) real-time square displacement (RTSD) as a function of time for 
stages I - V. (A) Stage I exhibits constrained motion with D = 3.07 x 10"10± 0.22 
x 10"10cm2 s"1. Scale bar = 10 pm (a) and 400 nm (b). (B) Stage II shows 
constrained motion with D = 9.73 x 10"10± 7.19 x 10 "10cm2 s"1. Scale bar = 10 pm 
(a) and 400 nm (b). (C) Stage III illustrates constrained motion with D = 9.91 x 
10"10 ± 8.35 x 10"10cm2 s"1. Scale bar = 10 pm (a) and 100 nm (b). (D) Stage IV 
displays constrained motion with D = 6.79 x 10~10 ± 3.27 x 10~10 cm2 s"1. Scale 
bar = 10 pm (a) and 600 nm (b). 
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Concentration-dependent developmental stage biocompatibility 
D. rerio embryos exposed to sub-lethal concentrations of Ag NPs at select 
stages revealed that NPs induced death, as well as a variety of morphological 
defects and the number of different types of defects and the severity of each 
increased with increasing concentration of NPs. Stage I resulted in an increasing 
percentage of deformities in Ag NP treated embryos as the concentration was 
increased (Fig. 20A) with a critical concentration at 0.5 nM. In stage I even 
exposure to the lowest concentration produced abnormalities. At higher 
concentrations, an increasing percentage of Ag NP treated embryos died; 
correspondingly, recovery of viable abnormalities also declined. At the highest 
tested concentration, a majority of embryonic death was observed (Fig. 20A) with 
the critical concentration at 0.06 nM. 
Embryos treated in stage II had high rate of death but did not show any 
signs of deformities (Fig. 20B) correlating with increasing NP concentration 
having a critical concentration at 0.2 nM. This stage appeared sensitive to the 
treatment with NPs causing death of the embryos. This was specific for this 
stage of development and most likely due to that during this stage of 
development the embryos are undergoing vast cellular movements and 
establishment of the early organ systems.53,54 During this period the germ layers 
of the embryos are also being established, the ectoderm, the mesoderm, and the 
endoderm, which will become all parts of the developed organism.53,54 Stage II 
of development is a time when the onset of gene expression is starting and 
combined with our findings of restricted diffusion of the nanoparticles in the 
chorion space, the nanoparticles are interacting with the increased proteins being 
expressed in the chorion space.56 This could affect the pathways during 
development causing an increase in death at this stage, which is directly related 
to the increase in the NP concentration. 
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Figure 20. Histograms displaying the distribution of effects resulting from 
treatment with Ag NPs and the supernatant on zebrafish. 
(A) Normally developed, deformed, and dead zebrafish vs. concentration of Ag 
NPs in stage I. (B) Normally developed and dead zebrafish vs. concentration of 
Ag NPs in stage II. Note: no deformities were observed in stage II. (C) Normally 
developed, deformed, and dead zebrafish vs. concentration of Ag NPs in stage 
III. (D) Normally developed, deformed, and dead zebrafish vs. concentration of 
Ag NPs in stage IV. (E) Normally developed and dead zebrafish vs. 
concentration of Ag NPs for stage V. Note: no deformities were observed in 
stage V. (F) Normally developed and dead zebrafish vs. concentration of 
supernatant removed from Ag NP washing. Note: no deformities were observed 
in supernatant treatment. 
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Stage III treatment resulted in an increasing percentage of deformities as 
the concentration was increased (Fig. 20C) with a critical concentration at 0.07 
nM. The critical concentration is the minimum concentration needed to affect at 
least 50% of the normal zebrafish population. Exposure to the lowest 
concentration in stage III produced no abnormalities. At higher concentrations, 
an increasing percentage of Ag NP treated embryos died and equally the 
recovery of viable abnormalities for stage III also declined. At the highest tested 
concentration, a total embryonic death was observed (Fig. 20C) with the critical 
concentration at 0.02 nM. 
Stage IV treated embryos resulted in increased deformities with the lowest 
concentration and remained consistently constant throughout Ag NP 
concentration rises (Fig. 20D). The critical concentration was determined to be 
0.02 nM. In stage IV even exposure to the lowest concentration produced 
abnormalities. At higher concentrations, a small increasing percentage of Ag NP 
treated embryos died. At the higher tested concentrations in stage IV, a majority 
of embryonic death was observed (Fig. 20D) with the critical concentration at 
0.02 nM. 
Stage V resulted in no morphological defects and only a slight increase in 
death rate (Fig. 20E) with a critical concentration at 0.07 nM. This is possibly 
due to that during stage V, the embryo is in the hatching stage and finishing its 
development.53 Untreated control embryos for stages I through V (0.00 nM) 
produced no abnormal embryos and embryo viability was within normal limits 
(Fig. 20A-F). Control embryos exposed to (nanoparticle-free) supernatant from 
the NP washing process showed minimal levels of toxicity at all tested 
concentrations (Fig. 20F). 
The effective dose for our acute studies was determined from our previous 
chronic studies.11 We treated stage I through V embryos acutely with various 
concentrations of Ag NPs (0 - 0.7 nM). Embryos were carefully monitored post 
treatment at 24, 48, 72, 96, and 120 hpf (Fig. 15B). We examined the defects 
associated with treatment of developing embryos with Ag NPs at each treated 
embryo developmental stage. Many morphological defects were observed in the 
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developing zebrafish, including abnormal finfold and tail development, cardiac 
malformation, yolk sac edema and acephaly as shown in Figure 21. Stages I, III, 
and IV all had defects whereas; stage II had high rate of death but did not show 
any signs of deformities. Stage V did not show any signs of abnormalities and 
death only slightly increased. The shared abnormality among stages I, III, and IV 
treated embryos was finfold abnormalities, typically affecting the median finfold 
region (Fig. 21A - C (a)). In normally developing embryos, the median finfold is a 
clear, thin membrane around the entire trunk region containing unsegmented fin 
rays. In treated embryos at stage I, III, and IV, the tissue structure of the finfold 
was disorganized and in the more severe cases, the shapes of the finfold and the 
developing fin rays were altered. Treated embryos from stages I, III, and IV also 
displayed as the second shared defect, an abnormal tail (spinal cord) flexure 
phenotype (Fig. 21A - C (b)). This defect was often accompanied by tissue 
abnormalities of the finfold. In normal developing embryos, the notochord and 
spinal cord develop straight to the posterior-most tip of the tail. In the treated 
embryos for these stages however, the tail region was flexed to some extent. In 
the more severely flexed embryos, the flexure was extreme and the overall 
length of the tail was reduced (Fig. 21A (b)). The tail flexure defect also 
increased in severity with increasing NP concentration. 
The types and majority of defects observed differed according to the 
developmental stage at treatment. Embryos treated with the higher Ag NP 
concentrations (0.06 and 0.6 nM) in stage I presented with acephaly, or absence 
of a developed head (Fig 21A (e, f)). The embryos had a small amount of tissue 
where the head would normally develop. The tissue was not a fully formed head 
but rather an irregular formed mass of tissue. The severe cases of acephaly 
recovered from the treatment were only found to occur in stage I of development 
and not in stages III and IV. This is most likely due to the specific time of 
development because in stage I of development, the cells are still in the process 
of cleaving to lay out the map to form the head and caudal regions of the 
developing organism. If cells do not divide properly in the head or tail region of 
the body axis, it will not fully develop. Previous studies have demonstrated that 
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Figure 21. Representative optical images of deformities observed in stages 
I, III, and IV after acute treatment with Ag NPs. 
(A) Stage I deformed zebrafish displaying (a) Unfold abnormality; (b) tail/spinal 
cord flexure; (c) cardiac malformation; (d) yolk sac edema and (e, 0 acephaly. 
(B) Stage III deformed zebrafish displaying (a) finfold abnormality; (b) tail/spinal 
cord flexure; (c) cardiac malformation and (d) yolk sac edema. (C) Stage IV 
deformed zebrafish displaying (a) finfold abnormality; (b) tail/spinal cord flexure; 
(c) cardiac malformation and (d) yolk sac edema. Scale bar = 500 pm. 
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inhibiting p38 kinase activity resulted in blastomeres on one side of the 
embryonic mass not to divide.57 In stage I treated embryos, the deformity type 
that was observed the most was found to be finfold abnormality (Fig 21A (a)). 
Treated embryos from stage I displayed an abnormal tail flexure phenotype, 
cardiac malformation, and edema, or swelling, of the yolk sac region as the 
second most common defect (Fig 21A (b-d)). In normally developing embryos, 
the yolk sac region is a bulbous area containing yolk that provides nutrients to 
the developing embryo and during the later developmental process, the yolk sac 
shrinks. In the affected treated embryos at stage I, however, the yolk sac region 
was swollen and enlarged. Embryos at stage I exposed to Ag NPs also 
displayed edema of the pericardial sac region. In contrast to normal embryos, in 
the stage I treated embryos; the pericardial sac region was swollen and enlarged 
(Fig 21A (c)). In severe cases, the pericardial sac was extremely large and the 
cardiac ventricle was decreased in size. Finally, a minority of treated embryos 
for stage I displayed the acephaly defect at high concentrations (Fig 21A (e, f)). 
Embryos treated in stage III presented with no acephaly displaying that 
the acephaly deformity was characteristic of stage I treatment only. In treated 
embryos at stage III, the most common types of deformities observed were 
finfold abnormality, abnormal tail flexure phenotype, cardiac malformation, and 
edema, or swelling, of the yolk sac region (Fig. 21B (a-d)). The findings of tail 
deformity correlates with stage III of development because this is when embryos 
begin somitogenesis and notochord formation, which is important for proper 
development of the axial skeleton, the vertebrate spinal column, and the skeletal 
muscle.55 Embryos at stage III exposed to Ag NPs also displayed edema of the 
pericardial sac region. In contrast to normal embryos, in the stage III treated 
embryos; the pericardial sac region was swollen and enlarged (Fig. 21B (c)). At 
the highest doses, the pericardial sac was extremely large and the cardiac 
ventricle was decreased in size. 
Embryos treated in stage IV presented with no acephaly and the most 
common type of deformity was not finfold abnormality, as in stages I and III, but 
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was observed to be cardiac malformation (Fig. 21C (c)). This is most likely due 
the stage of development during treatment with the NPs, because during stage 
IV of development, the heart is being formed and is preparing for its first 
contraction.53 A majority of embryos at stage IV exposed to Ag NPs displayed 
edema of the pericardial sac region. At the highest doses, the pericardial sac 
was extremely large and the cardiac ventricle was decreased in size (Fig. 21C 
(c)). Treated embryos from stage IV also displayed as the second most common 
defects, an abnormal finfold development, tail flexure phenotype, and edema, or 
swelling, of the yolk sac region similar to those findings for stages I and III 
treatment (Fig. 21C (a, b, d)). 
Finfold abnormalities accounted for majority of recovered events at stages 
I and III (Fig. 22A, B). At higher doses for stages I and III, an increasing 
percentage of events (but still a minority) included cardiac malformation, yolk sac 
edema, and tail flexure deformities (Fig. 22A, B). Cardiac malformation, at 
44.1%, accounted for majority of recovered events at stage IV (Fig. 22C). At 
higher doses for stage IV, an increasing percentage of yolk sac edema occurred 
and other minority events included finfold abnormality and tail flexure deformities 
(Fig. 22C). 
Possible reasons for the high dependence of type and severity of defects 
on the stage of development and concentration of NPs could be due to the 
following: (i) The NPs enter inside the chorion space of the embryo during the 
specific stage of development and affect the specific proteins, signaling, and 
developmental pathways during that period of development, (ii) An increase in 
number of NPs inside the chorion space of the embryo during the specific stage 
of development increases the altering effects of the protein, signaling, and 
developmental pathways during development increasing severity of the deformity 
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Figure 22. Histograms of the types of deformities vs. the percentage of 
zebrafish. 
After acute treatment at each concentration of Ag NPs, five types of deformities 
in (A) stage I and four types of deformities in (B) stage III and in (C) stage IV 
were observed. 
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Our results describe a range of developmental defects and death following 
exposure of developing zebrafish embryos to nanomolar concentrations of Ag 
NPs at particular embryonic stages of development. Specific developmental 
pathways of embryonic development are still unknown, such as, differentiation 
into specialized tissues and organs, specifically how cells communicate with 
each other, how they become committed to a certain fate, and how they 
formulate a pattern to become a structure.54,56 Stage dependent developmental 
responses to Ag NPs, shown here, in a dose dependent manner, demonstrates 
the possibility of being able to pick specific developmental pathways to create 
particular phenotypes and as potential developmental therapeutic agents to treat 
specific disorders and generate specific developmental mutation in zebrafish, by 
alteration of the time of application of the NPs. 
SUMMARY 
In summary, we examined the transport and diffusion of single Ag NPs in 
vivo at specific stages of development and the defects associated with treatment 
at specific developmental stages. Ag NPs were observed inside embryos of 
every treated developmental stage, demonstrating that Ag NPs can transport 
independent of the stage of the developing embryos and can be administered 
without outside influence, such as microinjection. Ag NPs can be used in 
developmental stage treatment in vivo assays for study of nanomaterials and 
their role in developmental biology. The transport and diffusion of NPs in the 
chorion space demonstrated that the viscosity of the developing embryonic 
environment could be documented at each stage of development using single NP 
optics. An increase in embryonic environmental viscosity and NP concentration 
correlated to an increase in death, which demonstrated NP interaction with 
transcribed biomolecules in the chorion space during development. Many 
morphological defects were observed in the developing embryo, including 
acephaly, yolk sac edema, abnormal finfold and tail development, and cardiac 
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malformations at each stage of development, corresponding to the stage of 
treatment. In general, the number of different types of defects and the severity of 
each varied with the stage of treatment and increased with increasing dose of 
NPs demonstrating the possibility of selectively targeting specific embryonic 
developmental pathways by altering the stage of development and dose of NPs 
for developmental therapeutic studies. The investigation of transport, diffusion, 
and biocompatibility of nanomaterials in specific stages of development of 
embryos at single NP level can offer new knowledge about the developmental 
processes and environment, and provide new insights into the mechanics of the 
developing embryo as well as aid in the finding for functional nano-
developmental treatments for various disorders in early development. 
METHODS 
Synthesis and Characterization of Ag NPs 
We synthesized Ag NPs (13.1 ± 2.5 nm), as we described previously.11,13, 
58 The design and construction of our DFOMS for imaging of single Ag NPs in 
solution and in single embryos has been described in detail in our previous 
studies.11,13,15,58"64 
Treatment and monitoring of Zebrafish Embryos 
Wildtype (WT) adult zebrafish (Aquatic Ecosystems) were maintained, 
bred, and collected, as described previously.11,59 16 embryos were tested per 
concentration, per stage of development for 2 hours in NPs; each experiment 
was repeated 3 times, totaling 48 embryos analyzed per concentration, per stage 
of development. Each developmental stage of embryos in the wells was directly 
imaged as described previously. 
Study and Characterization of Transport and Biocompatibility of NPs 
Stage II through V living embryos that had been incubated with 0.2 nM 
NPs for a given time (0-2 hours) were carefully rinsed with Dl water to remove 
external NPs, placed in a self-made microwell containing Dl water, and 
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immediately imaged to investigate the transport of NPs into embryos or untreated 
embryos were placed in a self-made microwell containing Dl water to image the 
diffusion and transport of NPs inside the embryos in real-time using our DFOMS 
by adding the Ag NPs directly to the microwell. 
To study the dose-dependent effects of NPs on embryonic development, a 
dilution series of washed Ag NP solutions (0, 0.02, 0.04, 0.05, 0.06, 0.07, 0.18, 
0.35, 0.53, 0.62, and 0.66 nM) were incubated acutely with 5 stages of embryos 
in egg-water for 2h. Each experiment was carried out at least 3 times and total 
number of embryos at 48 was studied for each individual concentration to gain 
representative statistics. NP concentrations were calculated as described 
previously.11 Embryos in egg-water in the absence of NPs and in the presence 
of supernatant were placed in two rows of the 24-well plates as control 
experiments to probe the effects of possible trace chemicals from NP synthesis. 
The embryos in the 24-well plates were incubated at 28.5°C, and directly 
observed at room temperature using an inverted Zeiss Axiovert microscope 
equipped with a digital color camera at 24, 48, 72, 96, and 120 hpf. 
Data Analysis and Statistics 
A minimum of 100 Ag NPs was imaged and characterized for each 
measurement of their sizes and stability in egg-water using HRTEM and DFOMS. 
A minimum of 300 NPs in total was studied for each sample via three repeated 
measurements. For real-time imaging of diffusion of single NPs into and in 
embryos over time, a minimum of 16 embryos was studied for each given 
concentration. For study of dose-dependent effects of NPs on embryonic 
development, a total number of 48 embryos were studied for each NP 
concentration and each control experiment over 120 hpf with a minimum of 12 
embryos studied in each measurement. 
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CHAPTER IV 
STUDY OF CHARGE DEPENDENT TRANSPORT, BIOCOMPATIBILITY AND 
TOXICITY OF 12 NM SILVER NANOPARTICLES USING ZEBRAFISH 
EMBRYOS 
INTRODUCTION 
Drug delivery using nanotechnology has become an exciting new area of 
interest for new innovative ways to use nanomaterials as drug delivery vehicles 
for both targeting and sensor of cellular changes in living systems and delivery of 
drugs to specific cells and tissues30'63,65^9J0. New drug delivery approaches are 
using nanotechnology as a type of nanomedicine to establish an earlier diagnosis 
and a new safer treatment option by using direct delivery methods to single cells 
for many diseases, including cancers71. With the potential for use of 
nanomaterials in a living system to directly target diseased ridden cells, it is 
important to explore the important biophysicochemical interactions the 
nanomaterials can have in and on living biological system. There are many 
different biophysicochemical factors that are important for how nanomaterials 
interact with a biological system. Size, shape, surface charge (zeta potential), 
functional groups, and ligands can all affect how a nanomaterial will behave and 
how it will affect the delivery or function of a drug to a target cell or diagnosis 
sensor system in a living in vivo system72, 73, 30, 74. To understand these 
interactions in more detail it is important to look at each factor and investigate 
how nanomaterials behave in a living in vivo system to anticipate potential drug 
delivery response. The biophysicochemical characteristics of nanoparticles can 
determine how biocompatible a nanoparticle will be in an in vivo system72. 
Surface charge has been shown to have an impact on the biocompatibility of a 
nanoparticle to a living system72. 
In this study we focused on how surface charge (zeta potential) influences 
how a single silver (Ag) nanoparticle transports and diffuses in a living zebrafish 
embryo system in real-time. We also examined the biocompatibility the different 
r 
57 
surface charged Ag nanoparticles had on the zebrafish system and how it 
influenced the embryonic development. Interaction of surface charged 
nanoparticles in a biological system, especially an embryonic developing system, 
is an interesting area of nanotechnology research. Greater understanding of 
developmental biology is crucial and utilizing nanoparticle technology and 
understanding the biophysicochemical interactions will allow more information to 
explore unknown mechanisms during development. 
It is not known whether Ag nanoparticles with different surface charges 
can enter the zebrafish embryo and what impact will they have on the developing 
system. Previous studies with gold nanoparticles on cells show strong 
correlation of surface charge and related toxicity75,76 Nanoparticles have unique 
surface chemistry which allows them to be conjugated with biomaterial (DNA, 
peptide, drugs etc,) for biomedical clinical purposes so it is important to 
investigate surface charge transport, diffusion, and biocompatibility on a living 
system77'78. 
We synthesized uniform Ag nanoparticles with three different surface 
charges and conducted studies for their transport and biocompatibility in 
developing embryos. Surface charge is important because it influences every 
aspect of nanoparticle function, uptake mechanisms and nanoparticle clearance. 
To our knowledge, there has been no significant research done to study the 
impact of surface charge of nanoparticles on the biocompatibility, toxicity, and the 
transport of these nanoparticles in an in vivo model system. There are however 
toxicity and biocompatibility studies done with other nanomaterials using cells as 
the model organism79"84. Also many studies have used nanoparticles as delivery 
agents in living systems85. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Stability of Ag Nanoparticles 
We synthesized sphere shaped Ag NPs as described previously and 
conjugated them with three different types of peptides, CALNNE (-), CALNNS 
(~0), CALNNK (+), producing NPs with different surface charges, as 
demonstrated in Figure 23 enabling the study of key surface charge dependent 
transport, diffusion, and biocompatibility to determine their behavior in vivo, 
including morphological responses and concentration dependent morphological 
responses, for potential use as drug delivery systems or developmental 
intermediates for biomedical applications70, 80. We characterized the zeta-
potential of our peptide Ag nanoparticles and determined the surface charge for 
Ag-CALNNK (+), Ag-CALNNS(-O), and Ag-CALNNE(-) to be 2.96 ± 0.19, - 5.04 ± 
0.09, -11.94 ± 0.94, respectively (Fig. 23B). 
We further characterized the purified Ag NPs conjugated with CALNNK (+), 
CALNNS (~0), and CALNNE (-) using transmission electron microscopy (TEM) 
and dark field optical microscopy and spectroscopy (DFOMS) (Fig. 24 - 26). The 
representative TEM image and TEM distribution for Ag-CALNNK (+) NPs in Fig. 
24 indicate that the majority of the NPs are spherical in shape and the average 
size is 11.5 ± 2.9 nm (Fig. 24A-B). The representative DFOM image shows that 
NPs are blue and green (Fig. 24C). The LSPR spectra of single Ag-CALNNK (+) 
NPs (blue and green), had peak wavelengths (Amax) at 508 nm, 554 nm and 585 
nm (Fig. 24D). 
For Ag-CALNNS (~0) NPs in Fig. 25 indicate that the majority of the NPs 
are spherical in shape and the average size is 12.3 ± 2.7 nm (Fig. 25A-B). The 
representative DFOM image shows that NPs are blue and green (Fig. 25C). The 
LSPR spectra of single Ag-CALNNS (~0) NPs (blue and green), had peak 
wavelengths (Amax) at 508 nm, 560 nm and 581 nm (Fig. 25D). 
For Ag-CALNNE (-) NPs in Fig. 26 indicate that the majority of the NPs are 
spherical in shape and the average size is 11.3 ± 2.5 nm (Fig. 26A-B). The 
representative DFOM image shows that NPs are blue and green (Fig. 26C). The 
LSPR spectra of single Ag-CALNNS (~0) NPs (blue and green), had peak 
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Figure 23. Illustration of synthesis and respective zeta-potentials of Ag-
peptide NPs for charge dependent transport studies in developing 
zebrafish embryo. 
(A) Illustration of (a) Ag-CALNNE (-), (b) Ag-CALNNS (~0), and (c) Ag-CALNNK 
(+) design. (B) Zeta-potential of (a - c) in (A) was -11.94 ± 0.94 mV, -5.04 ± 0.09 
mV, and +2.96 ±0.19 mV, respectively. 
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Figure 24. Characterization of size of Ag NPs and optical properties and 
stability of Ag-CALNNK (+) NPs. 
(A) Representative HRTEM image demonstrates the size and spherical shape of 
single Ag NPs. Scale bar =10 nm. (B) Histogram of size distribution of Ag NPs 
measured by HRTEM shows the average size to be 11.5 ± 2.9 nm. (C) 
Representative dark-field optical image of single Ag-CALNNK (+) NPs (a-c) 
shows that NPs are blue and green. Scale bar = 2 |jm. (D) LSPR spectra of 
single Ag-CALNNK (+) NPs (blue and green), with peak wavelengths (Amax) at (a) 















y m y  m y  m y  
y l£l>l£ 
6 8 10 12 14 16 18 20 
Diameter (nm) 
450 550 650 
Wavelength (nm) 
750 
Figure 25. Characterization of size of Ag NPs and optical properties of Ag-
CALNNS (~0) NPs. 
(A) Representative HRTEM image demonstrates the size and spherical shape of 
single Ag NPs. Scale bar = 20 nm. (B) Histogram of size distribution of Ag NPs 
measured by HRTEM shows the average size to be 12.3 ± 2.7 nm. (C) 
Representative dark-field optical image of single Ag-CALNNS (~0) NPs (a-c) 
shows that NPs are blue and green. Scale bar = 2 (D) LSPR spectra of 
single Ag-CALNNS (~0) NPs (blue and green), with peak wavelengths (Amax) at 
(a) 508 nm (FWHM = 68 nm), (b) 560 nm (FWHM = 88 nm) and (c) 581 nm 
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Figure 26. Characterization of size of Ag NPs and optical properties of Ag-
CALNNE (-) NPs. 
(A) Representative HRTEM image demonstrates the size and spherical shape of 
single Ag NPs. Scale bar = 20 nm. (B) Histogram of size distribution of Ag NPs 
measured by HRTEM shows the average size to be 11.3 ± 2.5 nm. (C) 
Representative dark-field optical image of single Ag-CALNNE (-) NPs (a-c) 
shows that NPs are blue and green. Scale bar = 2 |jm. (D) LSPR spectra of 
single Ag-CALNNE (-) NPs (blue and green), with peak wavelengths (Amax) at (a) 
506 nm (FWHM = 69 nm), 555 nm (FWHM = 98 nm) and (d) 595 nm (FWHM = 
111 nm). 
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We further characterized the stability of the purified Ag NPs conjugated 
with CALNNK (+), CALNNS (~0), and CALNNE (-) in egg-water embryo media 
(1.2 mM NaCI) for 120 hrs using DFOMS, UV-vis spectroscopy, and dynamic 
light scattering (DLS) (Fig. 27 - 29). The number of NPs/image (20 images) for 
Ag-CALNNK (+) indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 117 ± 3, 
115 ± 3, 116 ± 2, 115 ± 3, 113 ± 4, 115 ± 4 and 112 ± 3, respectively. This 
indicated that the NPs remained unchanged as NPs were incubated with egg-
water and were very stable over a period of 120h (Fig. 27A). The representative 
UV-vis absorption spectra for Ag-CALNNK (+) well-dispersed in egg-water at 
28°C for (a) Oh and (b) 120h demonstrates the peak absorbance at 0.083 and 
peak wavelength at 406 nm and they remain unchanged for 120h (Fig. 27B). 
The representative size distribution of stability of Ag-CALNNK (+) NPs in egg-
water media using DLS indicate at Oh the size is (a) 11.2 ± 2.5 nm and at 120h is 
(b) 11.3 ±2.6 nm (Fig. 27C). 
For Ag-CALNNS (~0) (Fig. 28), the number of NPs/image (20 images) 
indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 115 ± 3, 116 ± 4, 117 ± 3, 
117 + 4, 116±4, 115±3 and 115 ± 3, respectively. This indicated that the # of 
NPs remained unchanged as NPs were incubated with egg-water and were very 
stable over a period of 120h (Fig. 28A). The representative UV-vis absorption 
spectra for Ag-CALNNS (~0) well-dispersed in egg-water at 28°C for (a) Oh and 
(b) 120h demonstrates the peak absorbance at 0.158 and peak wavelength at 
406 nm and they remain unchanged for 120h (Fig. 28B). The representative size 
distribution of stability of Ag-CALNNS (~0) NPs in egg-water media using DLS 
indicate at Oh the size is (a) 12.8 ± 2.8 nm and at 120h is (b) 13.3 ± 2.9 nm (Fig. 
28C). 
For Ag-CALNNE (-) (Fig. 29), the number of NPs/image (20 images) 
indicate at to, 12h, 24h, 48h, 72h, 96h and 120h were 113 ± 3, 111 ± 2, 111 ± 2, 
110±4, 113 ± 2, 112±3 and 111 ±3, respectively. This indicated that the # of 
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Figure 27. Characterization of stability of Ag-CALNNK (+) NPs. 
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and 
120 h were 117 ± 3, 115 ± 3, 116 ± 2, 115 ±3, 113 ±4, 115 ±4 and 112 ±3. (B) 
Representative UV-Vis absorption spectra of Ag-CALNNK (+) NPs well-dispersed 
in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak absorbance at 0.083 
and peak wavelength at 406 nm (FWHM = 100 nm) and they remain unchanged 
for 120 h.(C) Histograms of size distribution of stability of Ag-CALNNK (+) NPs in 
egg-water media using DLS, (a) 11.2 ± 2.5 nm at 0 h and (b) 11.3 ± 2.6 nm at 
120 h. 
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Figure 28. Characterization of stability of Ag-CALNNS (~0) NPs. 
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and 
120 h were 115 ±3, 116±4, 117 ± 3, 117±4, 116±4, 115±3and 115±3. (B) 
Representative UV-Vis absorption spectra of Ag-CALNNS (~0) NPs well-
dispersed in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak 
absorbance at 0.158 and peak wavelength at 406 nm (FWHM = 101 nm) and 
they remain unchanged for 120 h. (C) Histograms of size distribution of stability 
of Ag-CALNNS (~0) NPs in egg-water media using DLS, (a) 12.8 ± 2.8 nm at 0 h 
and (b) 13.3 ± 2.9 nm at 120 h. 
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Figure 29. Characterization of stability of Ag-CALNNE (•) NPs. 
(A) The number of NPs/ image (20 images) at to, 12 h, 24 h, 48 h, 72 h, 96 h and 
120 h were 113 ±3, 111 ±2, 111 ±2, 110 ±4, 113 ±2, 112 ±3 and 111 ±3. (B) 
Representative UV-Vis absorption spectra of Ag-CALNNE (-) NPs well-dispersed 
in egg-water at 28°C for (a) 0 and (b) 120 h shows the peak absorbance at 0.091 
and peak wavelength at 401 nm (FWHM = 99 nm) and they remain unchanged 
for 120 h. (C) Histograms of size distribution of stability of Ag-CALNNE (-) NPs 
in egg-water media using DLS, (a) 11.9 ± 2.8 nm at 0 h and (b) 12.3 ± 2.8 nm at 
120 h. 
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stable over a period of 120h (Fig. 29A). The representative UV-vis absorption 
spectra for Ag-CALNNE (-) well-dispersed in egg-water at 28°C for (a) Oh and (b) 
120h demonstrates the peak absorbance at 0.091 and peak wavelength at 401 
nm and they remain unchanged for 120h (Fig. 29B). The representative size 
distribution of stability of Ag-CALNNE (-) NPs in egg-water media using DLS 
indicate at Oh the size is (a) 11.9 ± 2.8 nm and at 120h is (b) 12.3 ± 2.8 nm (Fig. 
29C). 
Transport, diffusion, and biocompatibility of nanoparticles in vivo 
We treated cleavage stage (64 cell, 2.25 hours post fertilization (hpf)) 
zebrafish embryos without the aid of any direct intrusion and followed their 
development for 120 hpf. Representative optical images of normal zebrafish 
development at treatment and throughout treatment in the absence of 
nanoparticles are shown in Fig. 30. 
To study the transport and diffusion of single Ag NPs in developing 
zebrafish embryos we incubated Ag-peptide NPs with cleavage stage embryos 
and were able to directly observe and characterize their transport and diffusion in 
real time using our DFOMS (Fig. 31). This allowed us to follow NPs and 
demonstrate their ability to travel through the chorion and into chorion space of 
the embryo and enter the inner mass of embryo regardless of the surface charge 
as shown in Figure 31B, a - c, respectively. Tracking NPs in the embryonic 
environment allowed us to probe diffusion of the different surface charged NPs, 
and determine the transport mechanism in an internal developing embryonic 
environment in real-time. For determining the transport mechanism of the 
nanoparticles in the embryonic environment, we used the concept of two-
dimensional mean squared displacement (MSD) and different modes of diffusion 
such as simple, directed and random Brownian motion. These models were 
used to analyze diffusion trajectory of the NPs in egg-water, along the chorion 
interface, in the chorion space of the developing embryo and inside the 
developing embryonic mass. Representative diffusion trajectory and plots of 
single Ag-peptide NPs interacting with the pores on the chorion interface of the 
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Figure 30. Representative optical images of normally developed zebrafish. 
(A) 0.75 - 2.25 hpf (cleavage-stage, at the time of treatment). (B) 24 hpf (late 
segmentation stage). (C) 48 hpf (hatching stage). (D) 72 hpf (pharyngula stage). 
(E) 120 hpf fully developed larvae. Scale bar = 500 pm. 
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Figure 31. Characterization of transport and diffusion trajectories of single 
Ag-peptide NPs at the chorion layers (CL), in the chorion space (CS) and at 
the inner mass of the embryo (IME). 
(A) Cleavage stage embryo, 2-4 hpf, demonstrating areas that were imaged (a) 
chorion interface, (b) chorion space, and (c) embryonic mass surface. Scale bar 
= 500 pm. (B) Representative optical images of Ag-CALNNK (+) NPs (circles) at 
the (a) CL (dashed lines), (b) inside CS and (c) at the IME. The square highlights 
the chorion pores in the CL. Scale bar = 10 pm. (C) Representative diffusion 
trajectories of Ag-CALNNK (+) NPs in the (a) CL, (b) CS and (c) IME. Scale bar 
= 100 nm (a), 1 pm (b) and 400 nm (c). (D) Representative plots of real-time 
square displacement (RTSD) as a function of time of the single green Ag-peptide 
NPs in the (a) CL, (b) CS and (c) IME. 
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developing embryo, in the chorion space and interacting with the inner embryonic 
mass (Fig. 31C, D) demonstrate varying diffusion coefficients (D). Due to the 
different embryonic environment at various locations, the diffusion coefficient can 
vary. Therefore we used real time square displacement (RTSD), instead of using 
the mean of the squared displacement allowing us to probe the diffusion of single 
silver in real time. The D of the single silver nanoparticles in simple Brownian 
motion was calculated by dividing the slope of the linear plot of the RTSD as a 
function of time divided by 4 (Fig. 31D). 
The results of the diffusion using the previous mentioned RTSD method 
showed that at the chorion layers (CL), (i) Ag-CALNNK (+), (ii) Ag-CALNNS (~0) 
and (iii) Ag-CALNNE (-) demonstrate constrained motion with D = (6.05 ± 3.77) x 
10"10 cm2 s"\ (2.11 ± 2.47) x 10"10 cm2 s"1 and (1.30 ± 0.95) x 10"10 cm2 s\ 
respectively. In the chorion space (CS), (i) Ag-CALNNK (+), (ii) Ag-CALNNS (~0) 
and (iii) Ag-CALNNE (-) demonstrate simple Brownian motion with D = (1.52 ± 
0.92) x 10"9 cm2 s1, (1.40 ± 0.26) x 109cm2 s'1 and (1.62 ± 1.53) x 10~9cm2 s"1, 
respectively. At the inner mass of the embryo (IME), (i) Ag-CALNNK (+), (ii) Ag-
CALNNS (~0) and (iii) Ag-CALNNE (-) demonstrate simple Brownian motion with 
D = (1.17 ± 1.48) x 10"9cm2 s \ (3.01 ± 3.81) x 10"9cm2 s 1 and (9.71 ± 7.18) x 10" 
10 cm2 s"\ respectively (Fig. 31D). 
Resultant data of treated normal, dead, deformed and control embryos are 
shown in Figure 32. Treatment with Ag-CALNNE (-) resulted in an increase 
death. When comparing the death rate of these NPs to Ag-CALNNK (+) NPs, 
80% embryos died in 0.6 nM, whereas zebrafish embryos treated at similar 
concentration with positive charged had higher percentage survival percentages 
(Fig. 32). Deformities in Ag-CALNNE (-) NP treated embryos were seen in 0.4 
nM and 0.6 nM concentrations. Death and deformities in treated embryos were 
found to be concentration dependent as with increasing nanoparticles substantial 
increase in death and deformities were seen in all types of charged 
nanoparticles. The supernatant was used as a control to ensure that no by-
f 
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Figure 32. Histograms displaying the distribution of effects resulting from 
chronic treatment with Ag-peptide NPs and their supernatant on zebrafish. 
(A) (a) Normally developed, deformed, and dead zebrafish vs. concentration of 
Ag-CALNNK (+) NPs. (b) Normally developed and dead zebrafish vs. 
concentration of supernatant (Sup) removed from Ag-CALNNK (+) NP washing 
and concentration of CALNNK (+) alone. (B) (a) Normally developed, deformed, 
and dead zebrafish vs. concentration of Ag-CALNNS (~0) NPs. (b) Normally 
developed and dead zebrafish vs. concentration of supernatant (Sup) removed 
from Ag-CALNNS (~0) NP washing and concentration of CALNNS (~0) alone. 
(C) (a) Normally developed and dead zebrafish vs. concentration of Ag-CALNNE 
(-) NPs. (b) Normally developed zebrafish vs. concentration of supernatant 
(Sup) removed from Ag-CALNNE (-) NP washing and concentration of CALNNE 
(-) alone. Note: no deformities were observed. 
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products from synthesis were contained in the NP solution and that the 
treatment response was due to the exposure of the Ag NPs and not the chemical 
used in the synthesis procedure. The percentage of normal zebrafish remained 
high even in the highest dose of supernatant confirming that the washing 
procedure carried out on Ag NPs prior to treatment and the chemical by­
products are not responsible for the deformities observed (Fig. 32b). 
We also examined individual defects associated with charged NPs and the 
morphological defects observed in zebrafish embryos included yolk sac edema, 
abnormal finfold and tail development, cardiac malformation and eye deformities 
in all types of charged nanoparticle treatment (Fig. 33). 
The number of defects and its severity were concentration and charge 
dependent. Severe defects like yolk sac edema, cardiac abnormalities and eye/ 
head abnormalities were higher in Ag-CALNNE (-) NPs as compared to Ag-
CALNNK (+) NPs. Emergence of deformities occurred more frequently in the Ag-
CALNNE (-) NP treated embryos as compared to the zebrafish embryos treated 
with the Ag-CALNNK (+) NPs. Fewer abnormalities were seen in zebrafish 
embryos treated with Ag-CALNNK (+) (Fig. 32 and 34). The most common 
deformity observed was a finfold abnormality and disorganization of the finfold 
tissue. In normally developed zebrafish embryos the fin rays are organized.24,53, 
86 
The second most common deformity observed in Ag-peptide NPs treated 
zebrafish embryos was cardiac malformation. Cardiac malformation was 
displayed as the edema of the pericardial sac region (Fig. 33c). The pericardial 
sac in embryos with this deformity was extremely large and cardiac arrhythmia 
was also observed. Zebrafish embryos treated with 0.6 nM Ag-CALNNE (-) 
concentrations demonstrated cardiac abnormality. At similar concentrations, Ag-
CALNNK (+), observed 0% cardiac deformities. 
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Figure 33. Representative optical images of deformities observed in 
zebrafish after chronic treatment with Ag-peptide NPs. 
(A) Ag-CALNNK (+) NP treated zebrafish displaying (a) finfold abnormality; (b) 
tail/spinal cord flexure and (c) cardiac malformation, (d) yolk sac edema and (e) 
no eye formation. (B) Ag-CALNNS (~0) NP treated zebrafish displaying (a) 
finfold abnormality; (b) tail/spinal cord flexure and (c) cardiac malformation, (d) 
yolk sac edema and (e) small eyes. (C) Ag-CALNNE (-) NP treated zebrafish 
displaying (a) finfold abnormality; (b) tail/spinal cord flexure and (c) cardiac 
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Figure 34. Histograms of the types of deformities vs. the percentage of 
zebrafish. 
(A) Ag-CALNNK (+) NPs, (B) Ag-CALNNS (~0) NPs and (C) Ag-CALNNE (-) 
NPs. 
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Another prevalent deformity observed in treated zebrafish embryos was 
yolk sac edema. In normally developing embryos, the yolk sac region is a 
bulbous area containing yolk that provides nutrients to the developing embryos 
and during the later developmental process, the yolk sac shrinks24, 53, 86 In 
embryos with yolk sac edema, the yolk sac region was swollen and enlarged 
(Fig. 33d). In many embryos yolk sac edema was simultaneously observed with 
cardiac abnormalities. Eye abnormalities, in the form of small eyes, were also 
widely seen in zebrafish embryos treated with our NPs (Fig. 33e). Percentage of 
eye abnormalities was significantly higher with Ag-CALNNE (-) as compared to 
Ag-CALNNK (+). While the Ag-CALNNK (+) observed only one eye/head 
abnormality at 0.4nM with Ag-CALLNS (~0) and Ag-CALLNE (-) treated embryos 
there was a higher frequency of eye/head abnormalities for 0.4 nM and 0.6 nM 
treatment concentration. Most frequent eye abnormalities observed were small 
eyes and disorganized development. All the deformities showed concentration 
and charge dependent phenomenon, with increase in nanoparticle concentration 
there was significant increase in overall deformities in zebrafish embryos in Ag-
CALNNS (~0) and Ag-CALNNE (-) NPs. 
Characterization of Ag nanoparticles embedded inside fully developed 
zebrafish 
We characterized Ag-CALNNK (+) embedded inside fully developed normal 
zebrafish that were chronically treated at the concentration 0.2 nM using 
DFOMS. From a transverse section (Figure 35A), we found that these Ag NPs 
were embedded in multiple areas (eye and brain) of a normally developed 
zebrafish (Fig. 35B, a-b, respectively). To confirm that these were NPs and not 
cellular debris from the zebrafish tissue, we took LSPR spectra of the NPs in the 
different areas (Fig. 35C). These results demonstrate that Ag-CALNNK (+) are 
biocompatible with developing zebrafish at given concentrations. We also 
performed a control experiment by imaging tissue sections of a zebrafish that 
developed in the absence of nanoparticles and did not observe the individual Ag 




Figure 35. Characterization of individual Ag-CALNNK (+) NPs embedded 
inside a fully developed normal zebrafish using DFOMS. 
(A) Optical image of a fixed transverse section of a normal zebrafish. The 
dashed rectangles highlight representative areas: (a) eye and (b) brain. Scale 
bar = 500 |jm. (B) Zoom-in optical images of those tissue sections outlined in 
(A). The circles highlight representative individual NPs embedded in the tissue 
sections that were characterized. Scale bar = 50 pm. (C) LSPR spectra of those 
single Ag-CALNNK (+) NPs circled in (B), with at (a) 551 nm (green) (FWHM 
= 111 nm) and (b) 532 nm (green) (FWHM = 98 nm). 
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SUMMARY 
In this study we were able to design and characterize different charged 
single Ag nanoparticle optical probes and follow their transport, diffusion, and 
toxicity in early development of zebrafish embryos in real-time to effectively 
monitor for an extended duration of time. We determined that the different 
charged nanoparticle optical probes could generate particular phenotypes in a 
dose dependent and charge dependent manner. We also demonstrated that 
negatively charged Ag nanoparticles exhibit more toxicity in the form of increased 
deformities and death at the same concentrations as the positively charged Ag 
nanoparticles. 
The negative charge of the NPs definitely contributed to the toxicity during 
the development of the embryo. At the same concentrations of positively 
charged Ag NPs, there were less overall deformities and less increase in death. 
According to our findings, it appears that positively charged Ag NPs are more 
biocompatible at higher concentrations; though the negatively charged Ag NPs 
were found to be biocompatible at a low concentration (0.1 nM) it seems that 
positive charged Ag NPs are more biologically compatible for a developing 
organism. Recent studies investigating nanoparticle toxicity have demonstrated 
that surface charge of the nanoparticle to be very significant in how a living 
system responds to the nanoparticle especially related to proper distribution and 
clearing from the body.72, 87"89 The results of our study indicate strong 
concentration and charge dependence for Ag NP biocompatibility in developing 
zebrafish embryos. 
Previous studies have shown that surface charge determines if and how a 
nanoparticle will get into cells.90 This is vital especially if looking at nanoparticles 
for use as delivery vehicles because if it cannot move inside the cell successfully, 
the drug or treatment will not be delivered.91 Additional studies have shown a 
significant relationship between surface charge and the ability to generate ROS 
causing inflammatory effects to living cells and tissues.92 A decrease in surface 
charge of Ag NPs can be considered as one central characteristic, which could 
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result in more toxicity.6 We determined from this experiment that our surface 
charged Ag NPs were able to transport and diffuse into our in vivo model system 
effectively without using any outside aid, for example, microinjection. It was 
determined that the surface charged Ag NPs were able to diffuse into the chorion 
via simple Brownian diffusion as we have observed in our previous studies.11 
The deformities that we observed were finfold, tail flexure, cardiac 
malformation, yolk sack edema, and eye malformation and these were 
dependent on the concentration of the surface charged Ag NPs as well as the 
charge. Recent studies using mice observed the similar toxicity findings and an 
inability for the mice to clear negatively charged NPs from their systems.93"96 The 
researchers found that negatively charged NPs in mice caused malformations 
related to clogging of nanoparticles in organ systems93"95. It was also determined 
that an increase in apoptosis was found to occur.96 
It is possible that the negatively charged Ag NPs are interacting with 
developmental pathways and interrupting dynamic events and causing several 
different deformities at one time. Further studies are underway to determine the 
cellular and molecular mechanisms involved in the toxicity. 
In conclusion, we were able to determine that positive and negative 
surface charged Ag NPs are able to transport, diffuse, and create toxic, as well 
as non-toxic effects on our zebrafish embryos. We were also able to determine 
that positively charged NPs are more biocompatible at higher concentrations 
than negatively charged Ag NPs. It was also determined that zebrafish embryos 
served as an effective in vivo model system, one that can be used to examine 
different surface charges of nanoparticles and determine which surface charged 
nanoparticles would be most biocompatible in a living system. 
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METHODS 
Synthesis and Characterization of Stability of Ag-CALNNK, Ag-CALNNS, 
and Ag-CALNNE NPs 
For Ag-CALNNK NPs, 50 ml of Ag NPs were synthesized as described 
previously. After 45 minutes of stirring, PEG-20 was added to a final 
concentration of 0.05% w/v under stirring. After 5 minutes of further stirring the 
solution was filtered through a 0.22 pm filter39,97 2.5 ml of the Ag NPs with 
PEG-20 was pipette into a 15 ml polypropylene tube. 10 such tubes were 
prepared. To each tube 34 pi of 28 mM buffered CALNNK was added drop by 
drop along the sides of the tube while vortexing the tube. The solution was then 
mixed on a shaker for 12 hours at 4°C. 
For Ag-CALNNS NPs, 50 ml of Ag NPs were synthesized as described 
previously. After 45 minutes of stirring, PEG-20 was added to a final 
concentration of 0.05% w/v under stirring. After 5 minutes of further stirring the 
solution was filtered through a 0.22 pm filter39,97 2.5 ml of the Ag NPs with 
PEG-20 was pipette into a 15 ml polypropylene tube. 10 such tubes were 
prepared. To each tube 57 pi of 17 mM buffered CALNNS was added drop by 
drop along the sides of the tube while vortexing the tube. The solution was then 
mixed on a shaker for 12 hours at 4°C. All three peptides were 0.5 mM 
Phosphate buffer pH 7.0 with 1.5 mM NaCI. 
For Ag-CALNNE NPs, Ag NPs were synthesized as described previously. 
PEG-20 was added to a final concentration of 0.05% w/v under stirring. After 30 
minutes of stirring the solution was filtered through a 0.22 pm filter39,97. 25 ml of 
the Ag NPs with sodium citrate dihydrate and PEG-20 was kept stirring. To it 630 
pi of 15 mM buffered CALNNE was added quickly. The solution was stirred at 
room temperature for 1 hour and then mixed for 12 hours at 4°C. 
The NPs were washed and characterized as described previously. 
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Breeding and Monitoring of Zebrafish Embryos 
We housed wild type adult zebrafish (Aquatic Ecosystems) in a stand­
alone system (Aquatic Habitats) and maintained, bred, and observed them as 
described previously.11,45 
In Vivo Characterization and Analysis of Transport and Dose-Dependent 
Biocompatibility and Toxicity of NPs 
Cleavage-stage living embryos (8-64 cell stage; 0.75-2.25 hpf) incubated 
with 0.2 nM NPs were characterized for transport and diffusion as described 
previously. 
To study the dose-dependent effects of NPs on embryonic development, a 
dilution series of washed peptide-conjugated Ag NP solutions (0, 0.1, 0.2, 0.4, 
and 0.6 nM) were incubated chronically with cleavage (8-cell) stage embryos in 
egg-water for 120 hpf. Each experiment was carried out at least three times and 
total number of embryos at 35-40 was studied for each individual concentration 
to gain representative statistics. Nanoparticle concentrations were calculated as 
described previously11. Embryo controls and observations were carried out as 
described previously. 
Characterization of NPs Embedded Inside Fully Developed Zebrafish 
Characterization of the embedded peptide-conjugated Ag NPs (0.2 nM) in 
the tissues of treated zebrafish, was done as described previously (Fig. 35). 
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CHAPTER V 
PROBING OF TRANSPORT, BIOCOMPATIBILITY AND TOXICITY OF SINGLE 
42 NM SILVER NANOPARTICLES IN EARLY DEVELOPMENT OF 
ZEBRAFISH EMBRYOS 
INTRODUCTION 
Nanoparticles have been increasingly used in consumer products, ranging 
from cosmetics, toothpastes, socks, home appliances, water treatment, to 
disinfection.98 Thus, it is crucial to study their potential nanotoxicity and 
environment impacts. Potential release of nanomaterials into aquatic 
environments would lead to a direct impact on human health, due to human 
consumption of fish and their ability to bioconcentrate trace contaminants from 
environment. In previous chapters, we studied transport and effects of smaller 
Ag NPs (11.6 ± 3.5 nm) on embryonic development and determined their 
chemical-dependence. In this study, we investigated the transportation and 
effects of stable and purified medium-sized Ag NPs (41.6 ± 9.1 nm) on 
embryonic development, aiming to better understand size-dependent transport 
and toxicity of Ag NPs. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of Stable and Purified Ag NPs 
Ag NPs were synthesized, purified and characterized, as described in 
Methods. Notably, highly purified Ag NPs were produced by thoroughly washing 
Ag NPs with deionized (Dl) water to remove potential residual chemicals involved 
in NP synthesis via centrifugation. The NPs were then suspended in egg-water 
(1.0 mM NaCI, embryonic medium) for study of their stability and their effects on 
embryonic development. 
HRTEM images of single Ag NPs and histogram of their size distribution 
(Figure 36A and B) show nearly spherical shaped NPs with average diameters of 
41.6 ± 9.1 nm, ranging from 33 to 51 nm. Dark-field optical images of single Ag 
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Figure 36. Characterization of stability and physicochemical properties of 
Ag NPs suspended in egg-water. (A) HRTEM image show spherical shape of 
single NPs. (B) Histogram of size distribution of single NPs determined by 
HRTEM show average diameters of 41.6 ±9.1 nm. (C) Dark-field optical image 
of single NPs shows that majority of NPs are plasmonic green (D) LSPR spectra 
of single NPs show Xmax (FWHM) at: (a) 458 (83); (b) 471 (75); (c) 543 (84); (d) 
594 (90) nm. (E) Number of individual NPs measured over time using DFOMS 
shows 131± 2, 131 ± 2, 134 ± 3, 134 ±4, 139 ± 5,133 ± 3 and 131 ± 4 per image 
at 0, 12, 24, 48, 72, 96, and 120 h. (F) UV-Vis absorption spectra of NPs in (E): 
(a) 0 and (b) 120 h show their peak absorbance at 0.87 with peak wavelength 
(FWHM) at 418 (100) nm remain unchanged over time, showing high stability of 
NPs in egg-water. Scale bars in (A) and (C) are 50 nm and 2 pm, respectively. 
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NPs suspended in egg-water (Figure 36C) show single plasmonic green NPs as 
majority with some blue and very few red NPs. Localized surface plasmon 
resonance (LSPR) spectra of representative single NPs (Figure 36D) show their 
peak wavelengths (Amax) with full-width-of-half-maximum (FWHM) at 458 (83), 
471 (75), 543 (84), and 594 (90) nm. 
The stability (non-aggregation) of the purified NPs in egg-water were 
characterized over the duration of embryonic development (120 h) at single-NP 
resolution using DFOMS, UV-vis absorption spectroscopy and dynamic light 
scattering (DLS). The number of NPs dispersed in egg-water (Figure 36E) 
remains unchanged over 120 h, indicating that NPs are stable (non-aggregated) 
in egg-water. Absorbance of UV-vis spectra of NPs in egg-water (Figure 36F) 
show that their absorbance of 0.87 with peak wavelength (FWHM) of 420 (100) 
nm remain unchanged for 120 h. Size distributions of NPs measured by DLS 
show their average diameters remain essentially unchanged at 45.5 ± 9.8 nm for 
120 h. Note that NPs are solvated in egg-water, which leads to larger diameter 
than those measured by HRTEM (Figure 36A, B). Taken together, these results 
demonstrate that NPs are stable (non-aggregated) in egg-water over the entire 
duration of embryonic development (120 h). Notably, contaminated unpurified 
chemicals would have attributed to observable toxicity and unstable NPs in the 
medium would lead to their size and dose changes over time, which had made 
the study of nanotoxicity unreliable. Therefore, purified and stable nanomaterials 
are essential for probing their size and dose dependent effects on living 
organisms. 
Real-Time Imaging of Transport of Single Ag NPs into/in Embryos 
We studied diffusion and transport of single NPs in cleavage-stage embryos by 
incubating NPs with the embryos and tracking their diffusion into and in embryos 
in real time using DFOMS. We first focus on probing of entry of single NPs into 
embryos from egg-water (outside chorion, OC) and then inside the embryos. 
Optical images of the embryos (Figure 37) illustrate interface of egg-water with 
chorionic space (CS) (chorionic layer, CL), CS, and interface of CS with inner 
mass of embryos (IME), and transport of individual NPs through these interfaces 
into IME. We found arrays of chorionic pore canals (CPCs) with diameters of 
0.5-0.7 |jm and distances among nearby pores at 1.5-2.5 |jm on CL of the 
embryos (Figure 37B) using DFOMS, which agree excellently with those 
characterized using scanning electron microscopy (SEM).25 Individual NPs 
diffused through chorionic pores to enter CS, then diffused in CS and finally 
entered into IME (Figure 37B-D). 
Notably, distinctive plasmonic optical properties (colors) of single Ag NPs 
enable them to be distinguished from debris, embryonic cells and tissues. Size-
dependent plasmonic properties of single NPs enable their sizes to be 
determined using DFOMS via optical nano rulers, as we described previously. 
The results show that single NPs with diameters of 33-51 nm can passively 
diffuse into the embryos. 
The diffusion modes of individual NPs were characterized as NPs were 
diffusing into/in embryos by tracking diffusion trajectories of single NPs and 
plotting real-time squared displacement (RTSD) versus diffusion time. Notably, 
embryonic environments are highly heterogeneous and change over time, as 
embryos develop. Thus, we used RTSD (diffusion distance at each time interval) 
rather than mean-squared displacement (MSD) (average distance over time) to 
investigate diffusion modes of single NPs. 
Plots of RTSD versus time for single NPs that were diffusing through CPCs 
into CS, in CS into IME, and IME show stepwise linearity, which suggests highly 
heterogeneous embryonic environments. As described by diffusion theories,26"28 
the linear plots indicate simple random Brownian motion and steps show 
restricted diffusion, suggesting that passive diffusion of single NPs (but not active 
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Figure 37. Real-time imaging of diffusion of single Ag NPs into single 
cleavage-stage embryos. (A) Optical image of cleavage-stage embryo in egg-
water. Chorionic layer (CL), chorionic space (CS), and the interface of the CS 
with inner mass of embryo (IME) are squared as (B-D), respectively. (B-D) 
Sequential dark-field optical images of zoom-in squared areas in (A), show the 
diffusion of single NPs (circle) from egg-water (outside chorion, OC) into CL, in 
CS into IME, and within the IME. The time intervals between sequential images 
in (B-D) are 1.1 s. See real-time Videos S1-3 in SI. Scale bars are 125 pm in (A) 
and 20 pm in (B-D). 
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cellular signaling) enable them to enter embryos. Individual NPs were trapped 
from time to time as they diffused from egg-water into CS and from CS to IME. 
Interestingly, single NPs were trapped more often in IME, which was more 
viscous than CS. 
Diffusion coefficients (D) of single NPs were determined by dividing the 
slopes of linear plots with four using two-dimensional (2D) Random walk theory 
(RTSD = 4DAt). They are (5.0±1.0) x10"11, (4.9±3.0) x10"9, and (5.1±8.5) x10"10 
cm2s"1 for single plasmonic green NPs going through CPCs from egg-water into 
CS, in CS into IME, and in IME. Diffusion coefficients of the single NPs in egg-
water measured using the same approaches are (5.2±1.8) x10"®cm2s"1. 
Notably, diffusion coefficients of single NPs are inversely proportional to 
viscosities of medium based upon Stokes-Einstein equation, D = kT/(6TTna), 
where k is Boltzmann constant; T is temperature; a is radii of single NPs; and q is 
viscosity of medium where NPs diffuse in. The results show that CL has the 
highest viscosity and IME has higher viscosity than CS. Embryonic 
environments are orders of magnitude more viscous than egg-water. The large 
standard deviations of diffusion coefficients of single NPs in embryos, especially 
in IME, show high heterogeneities (viscosity gradient) of embryonic 
environments. The results also demonstrate that single NPs can serve as optical 
probes to study embryonic nanoenvironments. 
Early-Development Embryos as Ultrasensitive In Vivo Assays 
Optical images in Figure 38A show normal developmental stages of 
zebrafish embryos, which includes cleavage (0.75-2.25 hours-post-fertilization, 
hpf), gastrula (10 hpf), segmentation (24 hpf), and hatching stages (48 hpf), and 
a fully developed zebrafish (120 hpf). All embryonic developmental stages of 
zebrafish are well defined. 
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Figure 38. Study of dose-dependent effects of Ag NPs on embryonic 
development using embryos as ultrasensitive in vivo assays. (A) Optical 
images of normally developing embryos at (a) cleavage-stage (0.75-2.25 hpf); (b) 
late gastrula stage (10 hpf); (c) late segmentation stage (24 hpf); (d) hatching 
stage (48 hpf); (e) fully developed larvae (120 hpf). (B) Dead embryo. (C) 
Histograms of distributions of embryos that developed to normal and deformed 
zebrafish or became dead versus NP concentration. (D) Control experiments: 
histograms of the distributions of embryos that developed to normal zebrafish or 
became dead either in egg-water alone or versus concentration of supernatant, 
which was collected from the last washing of NPs with Dl water. A total of 36 
embryos were studied for each NP concentration and control in (C-D). Scale bar 
is 500 |jm for all images in (A). 
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The earlier developmental stage, such as cleavage stage, is likely more 
prone and sensitive to the effects of external substances (e.g., drugs, NPs) than 
later stages. Notably, the cleavage-stage embryos undergo drastic changes to 
lay down foundation for developing different organs, and their related and 
important developmental mechanisms remains not yet fully understood.16, 18,51 
Thus, we select cleavage-stage embryos for study of transport, biocompatibility 
and toxicity of NPs, aiming to develop ultrasensitive in vivo assays for effectively 
screening of NPs and to rationally design biocompatible NP probes for in vivo 
imaging. 
Study of Dose and Size-Dependent Biocompatibility and Toxicity of Ag NPs 
We studied dose-dependent toxic effects of NPs on embryonic development by 
incubating cleavage-stage embryos with various concentrations (0-0.70 nM) of 
colloid Ag NPs suspended in egg-waters for 120 h. Representative embryonic 
developmental stages were imaged and assayed over time until the embryos 
were fully developed. Number of embryos that developed to normal zebrafish 
(Figure 38e), became dead (Figure 38B), and deformed zebrafish (Figure 39A) 
were recorded. 
The results in Figure 38C demonstrate high dependence of embryonic 
development upon the NP concentrations, or doses. As NP concentration 
increases from 0 to 0.7, the number of embryos that developed to normal 
zebrafish decreases, while the number of embryos that became dead increases. 
Interestingly, the number of embryos that developed to deformed zebrafish 
increases as NP concentration increases up to 0.2 nM. However, none of 
embryos survived beyond that, which is attributed to the decrease of deformed 
zebrafish and the increase of dead embryos at NP concentration higher than 0.2 
nM. 
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Severe deformities (e.g., cardiac abnormalities, yolk sac edema, and 
eye/head abnormalities) were observed at very low concentrations (< 0.2 nM), as 
summarized in Figure 39A. For example, finfold deformities with disorganized 
and improperly arranged finfolds (Figure 39A, a-b); abnormal tail flexing (spinal 
cord) with nearly 180° bent (c-d); cardiac malformations (edema of the pericardial 
sac region and cardiac arrhythmia) and Yolk sac edema with swollen and 
enlarged yolk sac (e); and head edema and severe eye abnormalities with 
micropthalmia (small eyes) and dissymmetric eyes (f-g), were observed at low 
concentrations (< 0.2 nM). These eye abnormalities were uncommon 
deformations and rarely reported. Notably, one severe deformation (e.g., 
cardiac, eye or head) observed in any given zebrafish was typically accompanied 
with several other types of deformations (e.g., finfold, tail and yolk sac edema). 
The results suggest that embryonic developmental pathways may be highly 
regulated and one pathway may highly depend upon others. 
Unlike our previous studies of smaller Ag NPs (11.6 ± 3.5 nm), more 
embryos died and developed more severe deformed zebrafish at the lower 
concentration, showing that the larger NPs are more toxic than smaller NPs. 
Two control experiments were conducted simultaneously by incubating the 
embryos with egg-water alone (blank control) and with the highest concentration 
of supernatants collected from the last washing of NPs, which had been 
thoroughly washed and stored in Dl water for at least five days. The 
supernatants were used to determine potential toxic effects of trace chemicals 
(e.g., Ag+) results from NP synthesis or degradation over time, which serves as 
control experiment to validate the observed toxicity in Figure 38C is attributed to 
NPs, but not other chemicals. The results from control experiments for embryos 
incubated with egg-water and the supernatants alone (Figure 38D) show that 


















Figure 39. Dependence of types of deformed zebrafish on NP 
concentration. (A) Optical images of deformed zebrafish show: (a-b) finfold 
abnormalities; (c-d) tail/spinal cord flexure; (e) cardiac malformation and yolk sac 
edema; and (f-g) eye abnormality. (B) Histograms of distributions of embryos 
that developed to deformed zebrafish with five distinctive types of deformities at 
NP concentration of 0.02, 0.05 and 0.10 nM. A total of 36 embryos were studied 
for each NP concentration and control. Scale bar is 500 pm for all images in (A). 
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were observed. Thus, the deformed zebrafish and high percent of dead embryos 
observed in Figure 38C were attributed to NPs, but not contaminated chemicals. 
Quantitative Characterization of Single Ag NPs Embedded in Zebrafish 
To address why some embryos developed normally while others were 
deformed or dead, we characterized single Ag NPs embedded in various tissues 
of zebrafish, which had been incubated with NPs (< 0.2 nM) chronically for 120 h, 
since they were cleavage-stage embryos. Longitudinal ultrathin sections (1-2 pm 
thickness) of representative deformed zebrafish with all types of deformities show 
NPs embedded in its eye (retina), brain, heart, and tail (Figure 40), as 
characterized by distinctive LSPR spectra of individual NPs. Interestingly, 
transverse ultrathin sections of normally developed zebrafish also show NPs 
embedded in the tissues similar to those of deformed zebrafish. The results 
suggest that NPs diffused into embryos and stayed inside the embryos 
throughout their entire development stages (Figure 41). The red shift of LSPR 
spectra of individual NPs embedded in the tissues may be attributed to the 
changes of their surrounding environments (e.g., dielectric constant of embedded 
medium), which differ from egg-water. 
The number of individual NPs embedded in eye (retina) and brain tissues 
of normal and deformed zebrafish (Figure 42) shows that more plasmonic blue 
and green (smaller) NPs were present in normal zebrafish, while more plasmonic 
red (larger) NPs were found in deformed zebrafish. Note that size-dependent 
plasmonic optical properties of single NPs enable us to determine their sizes in 
situ in real time using single NP optical ruler, showing that the red NPs are the 
largest NPs while the blue NPs are the smallest NPs. The results suggest that 
larger NPs are more toxic than smaller NPs, further demonstrating size-
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Figure 40. Characterization of individual Ag NPs embedded in deformed 
zebrafish using DFOMS. (A) Optical image of ultrathin longitudinal section of 
fixed zebrafish with five types of deformities. The rectangles highlight its (a) 
retina (eye), (b) brain, (c) cardiac, and (d) tail. (B) Zoom-in optical images of the 
tissue sections highlighted in (A) show embedded single NPs. (C) LSPR spectra 
of the individual NPs circled in (B) show Xmax (FWHM) at: (a) 682 (87), (b) 552 
(111), (c) 553 (94), and (d) 660 (106) nm. Scale bars are 500 pm in (A) and 50 
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Figure 41. Characterization of individual Ag NPs embedded in normally 
developed zebrafish using DFOMS. (A) Optical image of ultrathin 
transverse section of fixed zebrafish. The dashed rectangles outline its (a) 
retina, (b) lens, (c) forebrain, and (d) hindbrain tissues. (B) Zoom-in optical 
images of the tissue sections highlighted in (A) show individual embedded NPs. 
(C) LSPR spectra of representative single NPs circled in (B) show its A.max 
(FWHM) at (a) 553 (113), (b) 559 (134), (c) 675 (70), and (d) 552 (106) nm. 
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Figure 42. Study of sizes and number of individual Ag NPs embedded in 
both deformed and normal zebrafish. Histograms of the number and sizes 
(colors) of single NPs embedded in: (A) eye (retina) and (B) brain tissues of 
normally developed and deformed zebrafish. Tissues of 15 normal and 
deformed zebrafish each were analyzed. 
A (a) Normal and (b) Deformed Eye 
a 
Pl5 I & rJl 
Blue Green Red 
Plasmonic NPs 
(a) Normal and (b) Deformed Brain 
Blue Green Red 
Plasmonic NPs 
95 
The results also suggest that individual embryos may respond to 
nanotoxicity very differently. Some embryos may be more tolerant to 
nanotoxicity than others, underscoring the importance of study of biocompatibility 
and toxicity of NPs at single embryo resolution. Random diffusion of single NPs 
in embryos during their development may also play significant roles in creating 
nanotoxiciy, emphasizing the importance of study of nano biocompatibility and 
toxicity in real time at single NP resolution. Taken together, this study shows that 
early-developmental stage embryos can serve as ultrasensitive in vivo assays for 
effectively screening of biocompatibility and toxicity of NPs. 
SUMMARY 
In summary, we have designed, synthesized and characterized stable 
(non-aggregated) and purified Ag NPs with average diameters of 41.6 ± 9.1 nm, 
and developed DFOMS for imaging of single NPs in vivo in real time. We found 
that individual NPs passively diffused into embryos through chorionic pores of 
embryos, and stayed inside the embryos throughout the embryonic development. 
Dose-dependent toxic effects of NPs on the embryonic development were 
observed, showing that they were more biocompatible at lower doses and 
became toxic at higher doses. As NP concentrations increase, the number of 
embryos that developed to normal zebrafish decreases, while the number of 
embryos that became dead increases. In comparison with our previous studies 
of effects of smaller Ag NPs (11.6 ± 3.5 nm) on embryonic development, we 
found striking size-dependent toxic effects of NPs on embryonic development. 
Notably, larger NPs create higher toxic effects and more severe deformed 
zebrafish at the lower concentration than smaller NPs. This study offers new 
evidences of size-dependent nanotoxicity at single-NP resolution. 
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METHODS 
Synthesis and Characterization of Stable and Purified Ag NPs 
Ag NPs (41.6 ± 9.1 nm in diameter) were synthesized by quickly adding 
sodium citrate (10 mL, 34 mM) into a refluxing (100°C) AgN03 aqueous solution 
(500 mL, 1.1 mM) under stirring. The mixture was refluxed and stirred for 45 
min, as the solution color turned from colorless to straw yellow, then opaque and 
finally muddy yellow. The heating was stopped and the solution was cooled 
gradually to room temperature under stirring. The NP solution was filtered using 
0.22-|jm filters. All chemicals, except those indicated, were purchased from 
Sigma and used as received. 
The NPs were immediately washed three times as described previously. 
Sizes and stability of NPs were characterized as described previously. 
Breeding of Zebrafish Embryos 
Wild-type adult zebrafish were maintained and bred as described 
previously. 
Real-time Tracking of Diffusion of Single Ag NPs into/in Embryos 
The cleavage-stage embryos with egg-water were incubated with purified 
NPs (0.2 nM) and transport and diffusion was characterized as described 
previously. 
Study of Dose-Dependent Biocompatibility and Toxicity of NPs and Control 
Experiments 
The cleavage-stage embryos in egg-water were incubated with a dilution 
series of NPs (0, 0.02, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 0.7 nM) or (0, 5, 12, 24, 
48, 95, 119, and 166 pg/mL) and supernatant control experiments were carried 
out as described previously. Each experiment was carried out at least three 
times and a total number of 36 embryos were studied for each NP concentration 
and each control experiment to gain representative statistics and observations 
were done as described previously. 
Characterization of Single Ag NPs Embedded in Individual Zebrafish 
We characterized individual NPs embedded in the tissues of zebrafish as 
described previously (Figures 40-42). 
Data Analysis and Statistics 
A minimum of 100 Ag NPs was imaged and characterized for each 
measurement of their sizes and stability in egg-water using HRTEM and DFOMS. 
A minimum of 300 NPs in total was studied for each sample via three repeated 
measurements. For real-time imaging of diffusion of single NPs into and in 
embryos over time, a minimum of 15 embryos were studied for each given 
concentration with 5 embryos for each measurement. For study of dose-
dependent effects of NPs on embryonic development, a total number of 36 
embryos were studied for each NP concentration and each control experiment 
over 120 hpf with a minimum of 12 embryos studied in each measurement. 
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CHAPTER VI 
ASSAY OF TRANSPORT, BIOCOMPATIBILITY AND TOXCITY OF SINGLE 95 
NM SILVER NANOPARTICLES USING ZEBRAFISH EMBRYOS 
INTRODUCTION 
Advances in nanotechnology demand rational design of biocompatible 
nanomaterials and development of effective means and assays for well 
characterization and rapid screening of biocompatibility and toxicity of 
nanomaterials. Engineered nanomaterials possess distinctive physiochemical 
properties and promise wide ranges of applications from consumer products to 
health care.98"101 In this study, we synthesized and purified larger Ag NPs with 
average diameters of 95.4 ± 19.0 nm and used zebrafish embryos as in vivo 
assays to study the transportation and effects of the NPs on embryonic 
development. We compared the results from this study with those from our 
previous studies of transport and effects of smaller Ag (11.6 ± 3.5 nm) on 
embryonic development, aiming to better understand size-dependent transport 
and toxicity of Ag NPs. 
RESULTS AND DISCUSSION 
Synthesis and Characterization of 95 nm Ag NPs 
We synthesized and purified Ag NPs as described in the Methods. TEM 
images of purified single Ag NPs and their size distribution in Figure 43A and B 
show oval NPs with average diameters of (95.4±19.0) nm. Representative dark-
field optical image of single Ag NPs in Figure 43C show that majority of single 
NPs exhibit plasmonic green color with a few being blue and red. Localized 
surface plasmonic resonance (LSPR) spectra of representative single NPs show 
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Figure 43. Characterization of sizes, shapes, and plasmonic optical 
properties of single Ag NPs. 
(A) Representative HRTEM image show the sizes, shapes and morphologies of 
single Ag NPs. (B) Histogram of size distribution of single Ag NPs determined by 
HRTEM shows their average diameters as 95.4±19.0 nm. (C) Representative 
dark-field optical image of single Ag NPs shows individual plasmonic green, 
yellow and red NPs. (D) LSPR spectra of single Ag NPs (green, yellow, and red) 
show Amax (FWHM) at 558 (78), 610 (89) and 704 (91) nm, respectively. Scale 
bars are 200 nm in (A) and 2 pm in (B). 
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nm), 553 nm (FWHM, 89 nm), and 604 nm (FWHM, 91 nm), respectively (Figure 
43D). Size-dependent LSPR spectra of single NPs enable their sizes to be 
determined in situ in real time at the nanometer (nm) scale using DFOMS, as we 
reported previously. 
We characterized the stability (non-aggregation) of the purified NPs 
suspended in egg-water (embryonic medium) over 120 h at single NP resolution 
using DFOMS. The number of single NPs in 60 images acquired by DFOMS 
over 120 h remains essentially unchanged with around 133 NPs per image 
(Figure 44A), suggesting that the NPs in egg-water are very stable. If NPs were 
aggregated, the number of NPs in solution would have decreased and their sizes 
would have increased over time, which would have made the study of dose and 
size dependent toxic effects of NPs unreliable and irrelevant. Thus, it is crucial to 
characterize the stability of NPs at single NP resolution in situ in real time. In this 
study, DFOMS severs as a powerful tool to characterize the number and sizes of 
single NPs in situ and in real time. 
We further characterized the stability of NPs using ensemble 
measurements, UV-vis spectroscopy and DLS. UV-vis spectra of the NPs in 
egg-water over 120 h show their absorbance of 2.1 at 418 nm (FWHM, 100 nm) 
and 1.9 at a shoulder peak of 392 nm (FWHM, 100 nm) remain unchanged 
(Figure 44B). Size distributions of NPs incubated in egg-water over 120 h, 
measured by DLS (Figure 44C), show that their average diameters remain 
essentially unchanged, ranging from 98.2±19.5 nm to 95.3±19.6 nm. The sizes 
of hydrated NPs became slightly smaller after suspended in egg-water for 120 h, 
which is likely attributed to the exchange of surface molecules (citrate ions) with 
chloride ions in egg-water. Similar phenomena were observed previously. 
Taken together, the NPs are very stable (non- aggregation) in egg-water over 
120 h (duration needed for embryos to fully develop), enabling us to investigate 
their size and dose dependent transport into embryos and their effects on 
embryonic development over time. 
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Figure 44. Characterization of stability (non-aggregation) of Ag NPs in egg-
water. 
(A) The average numbers of single NPs per image acquired by DFOMS, for Ag 
NPs (2 pM) incubated with egg-water 28°C for 0, 12, 24, 48, 72, 96, and 120 h, 
are 133±2, 130±2, 135±3, 136±4, 135±3, 139±4 and 130±3, respectively. The 
number of NPs remains essentially unchanged. Totally, 60 images are acquired 
with 20 images per measurement at each time point, which allow single NP 
measurements to gain sufficient statistics and represent bulk analysis. (B) 
Representative UV-Vis absorption spectra of Ag NPs (2 pM) incubated with egg-
water at 28°C for (a) 0 and (b) 120 h shows the peak absorbances of 2.1 at 418 
nm (FWHM = 100 nm) and 1.9 at 392 nm (FWHM = 76 nm). Both remain 
unchanged over time for 120 h. 
102 
Embryos as Ultrasensitive In Vivo Assays 
Optical images of zebrafish embryos show their well-defined 
developmental stages, which include cleavage (0.75-2.25 hours-post-fertilization, 
hpf), gastrula (10 hpf), segmentation (24 hpf), and hatching stages (48 hpf), and 
a fully developed zebrafish (120 hpf). 
The earlier developing embryos (cleavage-stage embryos) are highly 
subjective to toxic effects of external substances. Therefore, they could serve as 
more sensitive assays for screening of biocompatibility and toxicity of 
nanomaterials than later stage embryos and fully developed fish. At cleavage 
stage, the embryos undergo drastic changes to formulate the development of 
different organs and their related developmental mechanisms remain 
unexplored.16,18,51 Thus, we chose cleavage-stage embryos as ultrasensitive in 
vivo assays to study transport and toxicity of 90s-nm Ag NPs (Figures 45-47). 
Entry of Single Ag NPs into Embryos and Diffusion Mechanisms 
To determine whether 90s-nm Ag NPs can enter embryos and their 
related transport mechanisms, we incubated NPs with cleavage stage embryos 
and directly tracked diffusion of single NPs into and in embryos in real time using 
DFOMS. The image of single live embryo in Figure 45A illustrates chorionic 
layer (CL), chorionic space (CS) and inner mass of embryo (IME). The 
snapshots of sequential optical images (Figure 45B-D) show that single NPs 
diffuse from egg-water into CS through chorionic pores (chorionic pore canals, 
CPCs) on CLs; single NPs diffuse in CS, and diffuse from CS into IME, 
respectively. Arrays of chorionic pores on CLs were observed and their 
diameters ranging from 0.5 to 0.7 pm were determined in vivo in real time using 
DFOMS (Figure 3.6B). Interestingly, NPs diffused into embryonic cells on the 
surface of IME were clearly visualized by DFOMS in real time (Figure 45D). 
Notably, single Ag NPs exhibit distinctive plasmonic colors, which enable 
them to be effectively distinguished from embryonic cells, membranes and debris 




Figure 45. Real-time probing of transport and diffusion of single Ag NPs 
into/in embryos. 
(A) Optical image of the representative cleavage-stage embryo shows the 
interfaces of chorionic layer (CL) with egg-water (outside chorion, OC), chorionic 
space (CS), and the interface of CS with inner mass of embryos (IME) as 
highlighted by (B), (C) and (D), where the transports of single Ag NPs are studied 
in real time, respectively. (B-D) Sequential dark-field optical images of: (B) the 
CL (as highlighted by dashed lines), (C) the interface of CS with IME (as marked 
by dashed lines), and (D) IME, show the diffusion of single Ag NPs (as circled) 
from outside the chorion (OC) in egg-water into the CL; in CS; and from CS into 
IME, respectively. The time interval between each sequential image is 1.1 s. 









Figure 46. Study of effects of Ag NPs on embryonic development. Optical 
images in (A-C) show: (A) cleavage-stage embryos (0.75-2.25 hpf), which are 
incubated with Ag NPs in egg-water for 120 h; and developed to (B) normal 
zebrafish (120 hpf); or deformed zebrafish in Figure 5 or became (C) dead 
embryo. Scale bars in (A-C) are 500 pm. (D) Histograms of percent distribution 
of embryos that developed to normal or deformed zebrafish or became dead 
show their dependence upon NP concentrations. As NP concentration 
increases, number of embryos developed to normal zebrafish decreases, while 
the number of embryos that developed to deformed and became dead increases. 
(E) Control experiments show the study of embryos incubated with supernatant 
resulted from washing NPs (instead of NPs) in egg-water. Histograms of 
distributions of embryos that developed to normal zebrafish or became dead 
show their independence on supernatant concentration. Over 90% of embryos 
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Figure 47. Study of dependence of types of zebrafish deformities upon NP 
concentration. 
(A) Representative optical images of deformed zebrafish show: (a-c) finfold 
abnormalities; (b) tail/spinal cord flexure; (c, d) cardiac malformation and yolk sac 
edema; and (d) eye abnormality. Scale bar = 500 (jm. (B) Histograms of 
distributions of percent of embryos that developed to multiple types of deformed 
zebrafish show their dependence upon NP concentration. As NP concentration 
increases, the percent of embryos with severe deformities and various types of 
deformities increase. 
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determined in vivo in real time by their size-dependent LSPR spectra using 
optical nano rulers as we described previously. The results in Figure 45 show 
that single NPs with diameters of 95.4±19.0 nm diffused into embryos via 
chorionic pores. 
We further determined the diffusion mechanisms and modes (e.g., random 
Brownian motion, directed or restricted diffusion) of single Ag NPs entry into the 
embryos and inside the embryos using diffusion theories. Viscosities inside living 
embryos vary greatly upon local embryonic environments, which alter over time 
as embryos develop. Thus, we used real-time square displacement (RTSD, 
diffusion distance at each time interval) instead of mean-squared displacement 
(MSD, average distance over time), to determine the diffusion modes and 
diffusion coefficient of single NPs as they diffused into and through embryos. 
Plots of RTSD of single NPs versus time show stepwise linearity, as 
single NPs diffuse through chorionic pores, in CS, and into IME. As described in 
diffusion theories, the linear plots of MSD versus time indicate simple random 
Brownian motion and the steps show restricted diffusion. Thus, the results 
indicate that passive diffusion of single NPs (but not directed diffusion) enable 
them to enter embryos. The plots show several steps, indicating that individual 
NPs were frequently trapped in chorionic pores as they diffused from egg-water 
into the embryos. Similar phenomena were observed as NPs diffused from CS 
into IME, indicating dense interface of CS with IME. 
We determined diffusion coefficients (D) of single NPs by dividing the 
slopes of the linear plots with four using two-dimensional (2D) Random walk 
theory (RTSD = 4DAt).28 They are (3.9±7.5) x10"11, (7.5±6.0) x10"9, and (7.8±8.2) 
x10"10 cm2s"1 for single NPs going through CL into CS, in CS, and into IME. 
Diffusion coefficients of the single NPs in egg-water measured using the same 
approaches are (2.8±0.5) xlO"8 cmV. The results suggest highly 
heterogeneous embryonic environments and higher viscosity at IME and CL. 
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Study of Dose and Size Dependent Toxicity of Ag NPs 
To determine the dose-dependent toxicity of NPs, we incubated cleavage-
stage embryos with various concentrations (0-2.0 pM or 0-5.7 pg/mL) of purified 
and stable Ag NPs 95.4±19.0 nm in egg-waters for 120 h, and imaged the 
embryos as they developed in situ in real time. This experimental design 
enables NPs passively diffuse into embryos without intervention and the study of 
their effects on embryonic development, which mimics the potential transport and 
effects of NPs on aquatic and eco- living organisms should NPs release to the 
environments. We also conducted two types of control experiments 
simultaneously by incubating the embryos with egg-water alone and with the 
highest concentration of supernatants collected from the third washing of NPs to 
determine effects of any potential residential chemicals from NP synthesis. 
Embryos at representative development stages were imaged and 
monitored over time for 120 h until the embryos were fully developed. Optical 
images in Figures 46A-C and 47 show cleavage-stage embryos, normal 
developed zebrafish, dead embryos, and deformed zebrafish, respectively. The 
number of embryos that developed to normal and deformed zebrafish and 
became dead was determined and plotted against concentrations of NPs and 
supernatants. The results in Figure 46 show that embryonic development highly 
depends upon NP concentration (dose). As NP concentration increases from 0 
to 2.0 pM, the number of embryos that developed to normal zebrafish decreases, 
while the number of embryos that developed to deformed zebrafish and became 
dead increases. 
In contrast, control experiments for embryos incubated with egg-water and 
supernatants alone (in absence of NPs) show that over 95% embryos developed 
to normal zebrafish and none of embryos developed to deformed zebrafish. 
Therefore, the deformed zebrafish and dead embryos observed in Figures 46 
and 47 were attributed to the NPs, but not residual chemicals from NP synthesis. 
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We examined individual morphological defects (phenotypes) of deformed 
zebrafish and found various types of deformation, which includes abnormal 
finfold and tail/spinal cord, cardiac malformation, yolk sac edema, and eye 
deformities (Figure 47A). The number of embryos developed to deformed 
zebrafish with high severity and multiple deformities increases as NP 
concentration increases (Figure 47B), showing dose-dependent phenotypes. 
Finfold deformities (e.g., disorganized and improperly arranged finfolds) 
and abnormal tail and spinal cord flexing (Figure 47A:ab) were observed in all 
studied concentrations. Note that normally developed zebrafish shows well 
organized finfold rays and straight tails (spinal cord) (Figure 46B). 
Interestingly, severe deformations, such as cardiac malformations (e.g., 
edema of the pericardial sac region and cardiac arrhythmia) and yolk sac edema 
with swollen and enlarged yolk sac (Figure 47Ac) were observed only at higher 
concentrations (s 1 pM). Deformed zebrafish with cardiac abnormalities quite 
often also shows swollen and enlarged yolk sac (yolk sac edema). In normally 
developed zebrafish (Figure 46B), the yolk sac (a bulbous area containing yolk 
that provides nutrients to embryonic development) is much smaller because they 
should shrink during later stages of embryonic development.24, 53, 86 Notably, 
severe eye abnormalities and head edema were observed, starting at relatively 
low concentrations (s 0.02 pM) and the number of deformed zebrafish with eye 
abnormalities increases as NP concentration increases. Such eye abnormalities 
were rarely observed for embryos that were exposed to smaller Ag NPs even at 
high concentrations or toxic heavy ions (e.g., Cd2+). 
Strikingly, individual zebrafish with one type of severe deformations (e.g., 
cardiac, eye or head) was typically accompanied with several other types of 
deformations (e.g., finfold, tail and yolk sac edema) (Figure 47Ad). Such 
interesting findings suggest that embryonic developmental pathways are highly 
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orchestra and one pathway likely highly depend upon others, which lead to 
multiple deformations in single zebrafish. 
By comparing the results of this study with those of our previous study of 
effects of smaller Ag NPs (11.6±3.5 nm in diameter) on embryonic 
development,11 we found that toxic effects of NPs highly depend upon their sizes. 
Larger number of embryos developed to severe deformed zebrafish and became 
dead as they were exposed to larger Ag NPs even at very low concentrations 
(95.4±19.0 nm; £ 0.020 pM). In contrast, the embryos developed to normal 
zebrafish, but not deformed zebrafish or became dead, as they were exposed to 
small NPs even at higher concentrations (< 80 pM; 11.6±3.5 nm).11 Taken 
together, the results show that the large NPs cause much higher toxic effects on 
embryonic development than small NPs, and embryos can serve as effective in 
vivo assays to screen biocompatibility and toxicity of NPs. 
Quantitative Imaging and Analysis of Single Ag NPs Embedded in 
Zebrafish 
To address why some embryos developed normally while others became 
deformed or dead, we further determined distributions of NPs in developed 
zebrafish, which had been incubated with 90s-nm Ag NPs (£ 2 pM) chronically 
for 120 h, since they were cleavage-stage embryos. Individual NPs embedded in 
various tissues of normal and deformed zebrafish were characterized using 
DFOMS. The ultrathin sections (1-2 pm thickness) of tissue samples were 
prepared as described in Methods. The results in Figure 48 show that NPs were 
embedded in both normally developed and deformed zebrafish and NPs were 
well distributed in eyes, hearts and brains of zebrafish, which indicates that NPs 
diffused into embryos and stayed inside the embryos throughout their 
developmental stages. 
The number and sizes of individual Ag NPs embedded in tissues were 
characterized using their distinctive plasmonic optical properties (colors), or size-
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Figure 48. Quantitative imaging of individual Ag NPs embedded in 
deformed zebrafish using DFOMS. 
(A) Optical image of longitudinal section of the fixed zebrafish with five types of 
deformations show areas of: (a) eye, (b) cardiac and (c) brain tissues, as 
squared in (a-c). (B) Zoom-in optical images of those tissue sections squared in 
(A). Individual Ag NPs embedded in the tissue sections are circled. (C) LSPR 
spectra of those single Ag NPs circled in (B) show distinctive Xmax (FWHM) of: (a) 
556 (97), (b) 558 (101), and (c) 549 (104) nm. (D) Histograms of distributions of 
the number of Ag NPs embedded in retina (eye) and brain of (a) normally 
developed zebrafish and (b) deformed zebrafish show higher number of 
embedded NPs in deformed NPs. The scale bars are 500 pm in (A) and 50 jjm 
in (B). 
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dependent LSPR spectras (Figures 48C). More NPs embedded in eye and brain 
tissues were found in deformed zebrafish than normal zebrafish (Figure 48D), 
suggesting dose-dependent toxic effects of NPs on embryonic development. 
The larger number of NPs accumulated inside the embryos throughout their 
development may lead to their deformation and dead. Nonetheless, individual 
embryos could have various degrees of tolerance to toxic effects of Ag NPs. 
Embryos with high degree of tolerance could survive and develop to normal 
zebrafish, while those with low degree of tolerance could develop to deformed 
zebrafish or become dead. Therefore, this study underscores the importance of 
study of effects of NPs on embryonic development at single NP and single 
embryo resolution. 
SUMMARY 
In summary, we have synthesized, purified and characterized Ag NPs 
(95.4±19.0 nm) that are stable (non-aggregated) in egg-water (medium of 
embryos; 1.5 mM NaCI) over the cause of entire embryonic development (120 h). 
The results show individual NPs passively diffused into embryos through 
chorionic pores, and stayed inside the embryos throughout entire embryonic 
development, demonstrating their ability of concentrating potential release of NPs 
into aquatic systems. NPs were observed in normal and deformed zebrafish that 
had been incubated with NPs for 120 h since they were cleavage-stage embryos. 
We found dose-dependent toxic effects of NPs on the embryonic development, 
and higher doses of NPs led to higher levels of toxic effects on embryonic 
development. As NP concentrations increase, the number of embryos that 
developed to normal zebrafish decreases, while the number of embryos that 
became dead and developed to deformed zebrafish increases. In comparison 
with our previous studies of effects of smaller Ag NPs (11.6 ± 3.5 nm in diameter) 
on embryonic development, we found size-dependent toxic effects of NPs on 
embryonic development and larger NPs are more toxic than smaller NPs. Taken 
together, our studies show that zebrafish embryos can serve as ultrasensitive in 
vivo assays to rapidly screen biocompatibility and toxicity of NPs and to 
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effectively monitor the transport and effects of potential release of nanomaterials 
into eco-systems. 
METHODS 
Synthesis and Characterization of 90s-nm Ag NPs 
We synthesized Ag NPs (95.4±19.0 nm in diameter) by rapidly adding 
sodium citrate (20 mL, 34 mM in Dl water) into AgN03 (500 mL, 1.06 mM in Dl 
water) under stirring and refluxing. The mixture was continuously refluxed and 
stirred for 95 min, while the colors of the mixture turned from colorless to straw 
yellow, then opaque yellow, and finally muddy yellow. We then turned off the 
heating mantle and continued refluxing and stirring the solution until it was cooled 
to room temperature. The NP solution was immediately filtered using 0.22-jjm 
filters and washed three times as described previously. The NP solution was 
characterized for size and stability as described in previous chapters. The 
concentrations of colloidal NP solutions were calculated using the approaches as 
we described previously. 
Breeding of Zebrafish Embryos 
Wild-type adult zebrafish (Aquatic Ecosystems) were maintained and bred 
as described previously. 
Real-time Imaging of Diffusion of Single Ag NPs into/in Embryos 
The cleavage-stage embryos in self-made microchambers containing egg-
water with purified and stable 90 nm Ag NPs (1 pM) were imaged in real-time to 
track the diffusion of single NPs into embryos and inside embryos as we 
described previously. 
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Quantitative Study of Dose-Dependent Toxicity of Ag NPs 
The cleavage-stage embryos were incubated with various concentrations 
of 90 nm NPs (0, 2x10"\ 2x10 3, 1.0, and 2.0 pM) or (0, 5.7X10"4, 5.7X10"3, 2.8, 
5.7 pg/mL) and supernatants as described in previous chapters. Zebrafish 
observations were done as described previously. 
Quantitative Imaging of Single Ag NPs Embedded in Individual Zebrafish 
The number and sizes of individual NPs embedded in the tissues of 
interest were quantitatively determined using their size-dependent LSPR spectra 
acquired by DFOMS and as described in previous chapters (Figure 48). 
Data Analysis and Statistics 
For study of sizes, shapes, LSPR spectra, and stability of single NPs, 300 
individual NPs were studied for each sample with a minimum of 100 NPs for 
each measurement. For real-time imaging of transport and diffusion 
mechanisms of single NPs into and in embryos over time, a minimum of 15 
embryos were studied for each given concentration with 5 embryos per 
measurement. For study of dose-dependent effects of NPs on embryonic 
development, a total number of 36 embryos were studied for each NP 
concentration and each control experiment with a minimum of 12 embryos 




In conclusion, as described in Chapter II, we utilized zebrafish embryos as 
our living in vivo model system to assess the transport, biocompatibility, and 
toxicity of our purified and biologically clean Ag NPs. By statistically comparing 
the distributions of normal, deformed and dead embryos, it was observed that the 
Ag NPs caused deformities and death in a concentration dependent manner. 
The NPs were stable in the egg-water media and were found to transport into the 
embryos by random diffusion. It was observed that the diffusion rates of the Ag 
NPs varied dependent upon the area of the embryo in which they were 
contained. These results taken together implied that the NPs caused dose 
specific deformity depending on the concentration of the nanoparticles and it was 
determined that at a low dose the nanoparticles were biocompatible within the 
embryonic system, causing no deformities. 
In Chapter III, we utilized our in vivo model system used in chapter I, and 
the same purified NPs to probe the stage dependent transport kinetics, 
biocompatibility and toxicity effects of nanoparticles on embryos at different time 
periods of development. The NPs were determined to enter and transport into 
the embryos by random diffusion independent of the time of development. It was 
observed that the Ag NPs caused deformities dependent on the concentration of 
the nanoparticles, as well as the time period during development that the 
nanoparticles were administered. These results taken together implied that the 
NPs cause stage specific deformities depending on the time of development that 
the nanoparticles were in contact with the embryo. 
Apart from bare Ag NPs, in Chapter IV, Ag NPs, which were surface 
conjugated with different peptides to yield different surface charges were also 
used to probe the nanoenvironments within our in vivo model system in real time. 
Using our state of the art DFOMS, we were able to observe Ag NPs inside the 
embryo regardless of the surface charge of the NP. It was observed that the 
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different surface charged Ag NPs caused deformities dependent not only on the 
concentration of the nanoparticles, but dependent on the charge of the 
nanoparticles. These results indicated that as the surface charge of the NP 
became more positive; the NPs became more biocompatible, or less toxic, 
causing fewer deformities. 
Drug delivery vehicles will have molecules conjugated on the NP's surface 
and it contributes to its charge on the surface, it was of interest to study the 
surface charge of the NPs and how it would affect the transport and 
biocompatibility of NPs in a living in vivo model system. These are important 
considerations to be taken into account when designing drug delivery vehicles, 
because they have to be able to transport in a living system to get where they 
need to go to deliver a drug. This study is a significant step forward in that 
direction by studying the transport kinetics inside a living system. 
In the chapters II, III and IV, the stability of purified NPs in egg-water media 
was comprehensively established before demonstrating the application of Ag 
NPs as optical probes in our in vivo model system. In Chapter V we were also 
able to establish the stability of our larger sized purified Ag NPs (42 nm) in egg-
water media to utilize them in our in vivo model system to assay the transport, 
biocompatibility and toxicity of larger sized nanoparticles on embryonic 
development. We observed that the 42 nm Ag NPs were able to transport inside 
the embryo by random diffusion and that the larger nanoparticles caused 
deformities dependent on the concentration of the nanoparticles. This was 
similar to findings in chapter II, however it was found that the larger sized NPs 
were much more toxic and less biocompatible at the same concentrations of the 
12 nm Ag NPs. These results taken together imply that smaller sized NPs are 
much more biocompatible as compared to larger sized 42 nm Ag NPs. 
Apart from using the 42 nm Ag NPs, we also wanted to use a larger sized 
Ag NP (95 nm) and explore their possible toxicity in our in vivo assay. In Chapter 
VI we established the stability of our 95 nm purified Ag NPs in egg-water media 
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and then used them to assay the transport, biocompatibility and toxicity on 
embryonic development. We observed 95 nm Ag NPs inside the embryo and 
were able to follow their transport into the embryonic mass despite their large 
size and from this it was determined that the Ag NPs were able to transport 
inside the embryo by random diffusion independent of the size. Deformities in 
embryonic development were observed in a concentration dependent manner, 
similar to findings in chapter II and V, however it was found that the 95 nm Ag 
NPs were much more toxic and less biocompatible at even very low 
concentrations in the pM range. These results taken together implied that the 
smaller sized NPs, 12 nm - 42 nm, were much more biocompatible as compared 
to the largest sized 95 nm Ag NPs. 
The results of the research mentioned in this dissertation have 
demonstrated that zebrafish embryos are a powerful in vivo model system to use 
to assay the transport, biocompatibility, and toxicity of different types of 
nanomaterials. This opens up the possibility of using this system as a standard 
assay to screen many different types of multi-functional NPs, including target-
specific nanomaterials. There is the possibility of using NPs as effective drug 
delivery vehicles by attaching desired drug molecules to the surface of NPs, so it 
is very important to collect preliminary data on how a NP will transport in a living 
system and if it will be toxic to living cells. To conclude, the chapters included in 
this dissertation have shown conclusively the versatile nature of using zebrafish 
embryos as an in vivo assay to screen different types of NPs by demonstrating 
their use as a living embryonic model system to screen different types of Ag NPs. 
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APPENDIX A 
GUIDELINES FOR HANDLING NANOMATERIALS 
Zebrafish Experiments 
All experiments involving live zebrafish and/or zebrafish embryos and 
nanoparticles were carried out in compliance with the guidelines set in IACUC 
protocol #: 11-030 entitled "NIRT: Design of Biocompatible Nanoparticles for 
Probing Living Cellular Functions and Their Potential Environmental Impacts" 
and was approved April of 2012. 
Handling Nanoparticles 
According to NIOSH, the following workplace tasks may increase the risk 
of exposure to nanoparticles: 
1. Working with nanoparticles in liquid media without the necessary 
protection (e.g., gloves, safety goggles) will increase the risk of skin or 
eye exposure. 
2. Working with nanoparticles in liquid media during pouring or mixing 
procedures, or where high risk of agitation is involved, will lead to an 
increased likelihood of inhalation of droplets, which may be formed. 
3. Generating nanoparticles in the gas phase in non-enclosed systems 
will increase the chances of aerosol release to the workplace. 
4. Handling nano-structured powders will lead to the possibility of 
aerosolization. 
The following guidelines from the University of Oklahoma Health Sciences 
Center were always followed when working with nanomaterials in the lab 
(http://www.ouhsc.edu/ibc/documents/NanoparticleGuidelines.doc), although all 
of these guidelines may not be applicable to the research work associated with 
this dissertation. 
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1. Lab coats were worn at all times. 
2. Gloves were worn when handling nanoparticles. Because skin exposure 
was a concern, gloves covered the hand and the wrist. 
3. Long arm sleeves were required where high levels of exposure due to 
splashes of solutions containing nanoparticles were anticipated. 
4. Standard lab safety goggles were worn. 
5. Whenever possible, work was performed in a chemical hood or biological 
safety hood. 
a. Aerosol producing activities (such as sonication, vortexing, or 
centrifuging) were never conducted on an open lab bench. 
b. Activities that were likely to release nanoparticles (such as opening 
and emptying of tubes) were not performed on an open lab bench. 
c. Solutions containing nanoparticles were handled over disposable 
lab bench covers. 
6. Hand washing facilities were provided in all labs. Hand washing was 
performed after handling nanoparticles. 
7. Lab bench tops and other surfaces had to be cleaned after each lab 
experiment using a cleaning solution (methanol) suitable for the type of 
nanoparticles being used. 
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